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ABSTRACT 
 
The design of osseous implants, either load bearing or not, with desired mechanical 
and surface features that promote integration with bone and avoid risks of bone resorption 
and implant failure due to shear stresses, is still a challenging endeavour. The mechanical 
stresses which the skeleton undergoes affect bone formation and resorption processes. 
Bone remodelling is often promoted by adequate stress/strain conditions which are able to 
prevent bone mass loss. The largely used metallic implants offer several advantages like 
easy shape casting and modelling but include also several drawbacks like high stiffness if 
compared with the mechanical properties of native bone. A new generation of bone 
prosthesis is therefore indispensable to overcome the limitations of the obsolete metallic 
devices.  
In the orthopaedic framework, promising results have been achieved in the recent 
decades by three-dimensional structures named scaffolds. It is mandatory for any optimal 
scaffold to act as a temporary three-dimensional support for cell adhesion, growth and 
mineral matrix deposition. Moreover, ideal scaffolds should be able to integrate into 
surrounding tissue and mimic the structure and morphology of the natural bone tissue. 
Strict requirements for scaffolds are biocompatibility, a design closely resembling the 
natural extracellular matrix, an appropriate surface chemistry to promote cellular 
attachment, differentiation and proliferation and a sufficient mechanical strength to 
withstand in vivo stresses and physiological loading. Finally, the degradation of the ideal 
scaffold should proceed in a controlled way, keeping a sufficient structural integrity until 
the newly grown tissue has replaced the scaffold's supporting functions.  
Coupling a three-dimensional porous scaffold and a load bearing structure with 
suitable mechanical properties it is possible to obtain a device where the osteoconductive 
and osteoinductive properties of the former are synergistically linked with the mechanical 
ones of the latter.   
In this work both the aspects – osteointegration and load bearing – of an ideal 
prosthesis have been investigated. Alginate/Hydroxyapatite composite scaffolds were 
developed to be used either as scaffolds for sub-critical defects or as coatings for load 
bearing non-metallic bone prostheses. In both cases the investigation aimed to select 
suitable components and casting procedures to obtain the best results. The features of the 
single components and of the final three-dimensional structure were extensively 
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investigated in order to obtain the most clarifying characterization both in terms of 
physical-chemical properties and in terms of biological responsiveness. 
  
The experimental section of this work involved physical-chemical analysis that 
helped to characterize both the organic and the inorganic components of the scaffold, 
respectively alginate and hydroxyapatite, before and after composite assembling. This 
investigation, based on several techniques (NMR, Rheology, XRD, Raman and TEM) 
allowed to characterize in detail the scaffold’s components and revealed the possibility of 
using the hydroxyapatite as a source of calcium ions for the gelification of the alginate 
without loosing the paramount osteoinductive properties of the mineral. Micro Computed 
Tomography (µ-CT) was employed to understand quantitatively the architectural features 
of the three-dimensional matrix obtained after alginate gel casting process. Moreover, this 
tool allowed to assess the influence of different manufacturing protocols (e.g. 
concentration of the components, casting temperatures) on the scaffold’s final structure. 
The results obtained by means of µ-CT coupled with the ones of Scanning electron 
microscopy (SEM) and confocal laser scanning microscopy (CLSM) analysis of the 
scaffolds showed an optimal interconnected porous structure with pore sizes ranging 
between 100 µm and 300 µm and over 88% porosity. Proliferation assays and SEM 
observations demonstrated that human osteosarcoma cell lines were able to proliferate, 
maintain osteoblast-like phenotype and massively colonize the scaffold structure.  
Once the in vitro behaviour of the structure was clear, in vivo tests were performed. 
Cone-like Alg/HAp scaffolds were tested on skeletally mature female New Zealand White 
rabbits and compared with positive (bioactive glass scaffold) and negative (without any 
implant) controls. Ex vivo investigations of the dissected samples were based on µ-CT and 
histological analysis and revealed high level of osteointegration and osteoconduction of the 
scaffolds. 
Moreover, efforts have been made to link the porous structure to the non-metallic 
fibre reinforced composite used as load bearing unit. Overall, these combined results 
indicate that the structure here developed is promising for being employed in orthopaedic 
applications. 
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SOMMARIO 
 
L’ottenimento di impianti ossei con le opportune proprietà meccaniche che possano 
promuovere l’integrazione con il tessuto osseo circostante è ancora una sfida aperta nel 
campo dell’ingegneria tissutale. Gli stress meccanici a cui la struttura ossea è soggetta, 
influenzano notevolmente lo sviluppo e il rimodellamento del tessuto osseo. Gli impianti 
metallici, largamente utilizzati in campo ortopedico, offrono notevoli vantaggi dal punto di 
vista produttivo, manifestando però sostanziali limiti, ad esempio una differenza troppo 
elevata tra le caratteristiche meccaniche delle protesi e quelle del tessuto osseo nativo. Per 
questo motivo, alle protesi ossee metalliche sono spesso associati fenomeni di 
riassorbimento osseo, dovuti a stress meccanici, in grado di condurre al fallimento 
dell’impianto stesso.  
In campo ortopedico è pertanto necessaria una nuova generazione di impianti ossei in 
grado di sopperire ai limiti delle protesi metalliche. L’ingegneria tissutale, ormai da 
qualche decennio, ha offerto una valida alternativa a questo tipo di impianti dando origine 
a delle strutture in grado di mimare le proprietà strutturali e biologiche dell’osso 
trabecolare. Tali strutture, denominate scaffold (impalcatura), sono state concepite come 
dei supporti cellulari temporanei in grado di garantire una perfetta integrazione con il 
tessuto nativo. A tal fine, è necessario che il costrutto sia: biocompatibile, strutturalmente 
identico all’osso trabecolare, che presenti un’appropriata natura e composizione chimica in 
grado di promuovere l’adesione, il differenziamento e la proliferazione cellulare. Infine, 
uno scaffold ideale nell’ambiente biologico deve bilanciare fenomeni di biodegradazione e 
bioerosione garantendo integrità strutturale e funzionale fino alla completa formazione di 
nuovo tessuto osseo maturo. Le scarse proprietà meccaniche degli scaffold finora 
sviluppati, hanno reso necessario il loro utilizzo combinato a sistemi di fissaggio esterni 
che possano in qualche modo sostenere i carichi a cui l’osso è normalmente sottoposto. 
Se lo scaffold però viene concepito come una copertura per un impianto non 
metallico dotato di proprietà meccaniche del tutto simili a quelle dell’osso si ottiene un 
costrutto che associa le proprietà osteoinduttive e osteoconduttive dello scaffold con quelle 
meccaniche dell’impianto. 
Nel presente studio ci si è occupati di alcuni aspetti fondamentali relativi allo 
sviluppo di una protesi ideale di nuova generazione; particolare attenzione è stata rivolta 
alle proprietà meccaniche e osteointegrative della protesi. Scaffold compositi di alginato e 
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idrossiapatite sono stati qui sviluppati per essere utilizzati come coperture per protesi 
polimeriche a base metacrilica, ma anche come riempitivi per difetti ossei non critici. In 
entrambi i casi l’indagine ha condotto alla scelta dei componenti e delle procedure più 
adatti per la realizzazione del costrutto finale. Le proprietà dei singoli componenti del 
costrutto sono state analizzate dettagliatamente per garantire un’esaustiva caratterizzazione 
delle loro proprietà chimico-fisiche e della loro biocompatibilità. Queste analisi, basate su 
diverse tecniche, come la risonanza magnetica nucleare, la diffrazione a raggi X, la tecnica 
Raman e la microscopia elettronica a trasmissione, hanno permesso di caratterizzare i 
componenti, organico (alginato) e inorganico (idrossiapatite), dello scaffold. 
L’utilizzo della microtomografia computerizzata ha fornito la possibilità di indagare 
qualitativamente e quantitativamente l’architettura dello scaffold. Questa indagine ha 
condotto alla determinazione dei parametri di porosità e di dimensione trabecolare della 
struttura costituente lo scaffold e ha permesso di metterli in relazione a quelli caratteristici 
dell’osso trabecolare umano, constatando l’elevata analogia tra la struttura “artificiale” qui 
sviluppata e quella naturale dell’osso trabecolare. 
I test cellulari in vitro e le osservazioni tramite microscopia elettronica degli 
osteoblasti hanno permesso di verificare la corretta proliferazione cellulare e la 
colonizzazione della struttura. 
Dopo aver studiato esaustivamente in vitro le proprietà biologiche della struttura 
sono stati condotti test in vivo, ottenendo così preziose informazioni sulle caratteristiche 
osteoconduttive dello scaffold. 
Sono state infine considerate le possibili strategie di ancoraggio della struttura porosa 
osteoconduttiva alla superficie esterna del supporto metacrilico. 
 
L’insieme dei risultati ottenuti ha permesso di considerare i costrutti qui sviluppati e 
caratterizzati come promettenti alternative alle protesi metalliche in campo ortopedico. 
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1. INTRODUCTION 
 
1.1 Orthopaedic needs 
 
According to the literature, the diseases related to bones and joints account for half of 
all chronic diseases in people over 50 years of age in developed countries affecting 
millions of people worldwide (Navarro et al., 2008). The percentage of persons over 50 
years of age affected by bone diseases is in rapid increase and will double by 2020 
(http://www.boneandjointdecade.org). Numerous bone fractures, low back pain, 
osteoporosis, scoliosis and other musculoskeletal problems often require surgery and the 
use of permanent, temporary or biodegradable devices. Moreover, extensive bone loss due 
to pathological events such as trauma, inflammation and surgical treatment of tumours lead 
to the regeneration of large bone segments which still remains a significant clinical 
problem (Cancedda et al., 2007). Present therapeutic approaches include bone graft 
transplants (autologous, homologous or heterologous grafts), implants of different 
biomaterials and bone transport methods.  
Though containing all the key elements required for bone repair – an 
osteoconductive scaffold; growth factors for osteoinduction and vascularisation of the new 
bone/implant and cells with osteogenic potential – bone grafts present several major 
inconveniences when used in clinical practice. Albeit the percentage of success is high, 
complications (Charles et al., 2007; Pritsch et al., 2007), or non-unions (Muramatsu et al., 
2003; Soucacos et al., 2006) are common especially in large shaft reconstructions (Weiland 
et al., 1983; Sowa and Weiland, 1987; Taylor, 1983; Enneking et al., 1980; Delloye, 2003). 
Additionally, significant donor site morbidity is often the result of harvesting autologous 
bone (Laurie et al., 1984). Allografts and xenografts, respectively coming from human 
cadaver or animal sources, prevent the problem of the donor site morbidity, but presents 
the potential risk of viral or bacterial infections and of an immune response of the host 
tissue after the implant (Stevenson, 1987; Lord et al., 1988; Mankin et al., 1987; Alman et 
al., 1995). However, the continuous amelioration of the processing procedures for grafts is 
significantly reducing the risk of infections (Kwong et al., 2005; Yates et al., 2005; Mroz 
et al., 2006). In order to avoid residual risk of bacterial or viral transmission, additional 
coatings of antibiotics are also being studied (Alt et al., 2006; Nablo et al., 2005).  
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Biomaterials implant strategies are based on the use of different types of matrix, e.g. 
hydrogels, microspheres/beads, three-dimensional scaffolds, alone or in combination with 
growth factors and/or cells. These strategies aim to repair/regenerate the tissue by 
delivering cues to the cells of the host tissue which are expected to migrate, proliferate, and 
finally differentiate in the defect site. A further and mostly applied strategy focuses on 
seeding and culturing specific cell types in a 3D environment that aims to mimic the 
natural extra cellular matrix as closely as possible. Such 3D environments are achieved 
with sandwich cultures, hydrogels, and cells in specifically configured cellular solids also 
defined as scaffolds (Hutmacher et al., 2007).  
Surgical treatments of large bone defects with bone transport methods (Ilizarov 
method) (Ziran et al., 2007; Grayson et al., 2009) take advantage of the regeneration 
potential of bone. Although all problems related to graft integration are avoided, the 
procedure is highly inconvenient for the patient, requires a long recovery period and has a 
high complication rate (Cancedda et al., 2003). 
 
1.2 Bone Tissue Engineering 
 
According to a widely accepted definition: Tissue Engineering (TE) is ‘‘an 
interdisciplinary field of research that applies the principles of engineering and the life 
sciences towards the development of biological substitutes that restore, maintain, or 
improve tissue function’’ (Langer and Vacanti, 1993). In contrast to classic biomaterials 
approach, TE is based on the knowledge of tissue formation and regeneration processes, 
and aims to induce the formation of new functional tissues, rather than just to implant new 
spare parts. Researchers hope to reach this goal by combining knowledge from physics, 
chemistry, engineering, materials science, biology, and medicine in an integrated manner.  
TE covers a wide range of fields in terms of organic application. Our interest is 
addressed on the application of TE in the orthopaedic direction (i.e. Bone Tissue 
Engineering). Bone Tissue Engineering (BTE) is nowadays focused on materials and 
structures that enhance bone regeneration, overcome the mechanical shortcomings of metal 
and ceramic implants and which have a wealth of potential clinical applications from the 
treatment of non-union fractures to spinal fusion. Both metal and ceramic implants do 
present several disadvantages. Metals, for instance, although providing immediate 
mechanical support at the site of the defect, exhibit poor overall integration with the tissue 
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at the implantation site, and can fail because of infection or secondary due to fatigue 
loading or shear stresses. On the other hand ceramics have very low tensile strength and 
are brittle and, thus they cannot be used in locations of significant torsion, bending, or 
shear stress.  
The use of porous material generally called scaffolds from bioceramic and polymer 
components to support bone cell and tissue growth is a longstanding area of interest. 
Current challenges include the engineering of materials that can match both the mechanical 
and biological context of real bone tissue matrix and support the vascularisation of large 
tissue constructs.  
 
1.3 Biomaterials for Bone Tissue Engineering applications 
 
Whilst in the last 50 years tremendous advantages have been made in the 
biomaterials field, at present strong requirements in bone and joint substitution and the 
repair and degeneration of bone defects are still to be overcome. In this framework, 
biomaterials have evolved through three different generations. 
According to the definition of the European Society for Biomaterials, a biomaterial is 
a “material intended to interface with biological systems to evaluate, treat, augment or 
replace any tissue, organ or function of the body” (European Society for Biomaterials, 
1991). As Hench and Polak report in their key article published in 2002 (Hench and Polak, 
2002), biomaterials have evolved and can now be considered “third-generation 
biomaterials”. Initially, biomaterials were chosen because of their biological inertness, the 
goal was to minimize the body’s immune response to the foreign material. Though this 
goal is still valid today, scientists have come to understand that complete biological 
inertness is synonym to non-recognition by the body. This lack of biological recognition is 
often accompanied by fibrous tissue encapsulation and chronic inflammation, which in turn 
compromise the mechanical performance and long-term biocompatibility of the prosthesis. 
Thus, second-generation biomaterials were developed seeking to tailor or enhance 
biological recognition in an attempt to improve the biomaterial-body interface. 
Second generation biomaterials used bioactive components that could elicit a 
controlled action and reaction in the physiological environment. Two very typical 
examples of these components are synthetic hydroxyapatite (HAp) and Bioactive Glass 
(BG). Both were used as porous scaffolds, coatings or powders, and by the mid-80s these 
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new bioactive materials had attained clinical use for various dental and orthopaedic 
applications. The biomaterial-body interface problem was also addressed by exploiting 
resorbable materials, thus eliminating the interface all together. Third generation 
biomaterials aims to interact with distinct integrins, stimulate cell differentiation or activate 
certain genes to stimulate precise cellular responses. Therefore, properties of bioactivity 
and resorbability are being combined to create materials capable of helping the body repair 
itself better or faster than it could do on its own. Typically, biomaterials can be divided 
into: metals, ceramics, natural polymers and synthetic polymers. Composite materials may 
be defined as those materials that consist of two or more fundamentally different 
components that are able to act synergistically to give properties superior to those provided 
by either component alone. (Williams, 1999) 
 
1.3.1 Metallic Materials 
 
Metallic prostheses are nowadays the most diffuses implants in orthopaedic fields. 
Four of the 10 most frequent orthopaedic operations per year in the United States, involve 
metallic implants: open reduction of a fracture and internal fixation (1st on the list); 
placement or removal of an internal fixation device without reduction of a fracture (6th); 
arthroplasty of the knee or ankle (7th) and total hip replacement or arthroplasty of the hip 
(8th) (Brunski, 2004). Metallic materials, due to their inertness represent an example of 
first-generation biomaterials being developed when third-generation biomaterials were 
already in use.  
None of the metallic materials used in orthopaedics is bioactive per se. However, two 
approaches can be considered to obtain bioactive metals. The first one consists of coating 
the surface of the implant with a bioactive ceramic hydroxyapatite (HAp) or bioactive 
glass (BAG). The second one is to chemically modify the surface of the material to 
promote in vivo the natural deposition of a bioactive ceramic or to induce proteins 
absorption, cell adhesion and other tissue/material interactions (Navarro et al., 2008).  
One of the worst shortcomings of metallic devices is that these prostheses, on contact 
with bone, will take most of the load due to their high modulus, producing stress shielding 
in the adjacent bone. The lack of mechanical stimuli on the bone may induce its resorption 
that will lead to the eventual failure and loosening of the implant (Huiskes et al., 1992; 
Bauer and Schils, 1999). Bone formation and resorption processes during healing of 
injured sites, depend on the mechanical environment of the native bone contour (Huiskes et 
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al., 1992; Bauer and Schils, 1999). Load-bearing osseous implant must be endowed with 
the desired mechanical and surface properties in order to promote incorporation with bone 
and to eliminate risk of bone resorption and implant failure. Therefore, to promote new 
bone growth and to prevent bone mass loss certain stress/strain conditions are required. 
Conventional metallic implants with high stiffness carry most of the load and the 
surrounding bone becomes virtually unloaded and inactive.  
A valid alternative to the metals is represented by the fibre-reinforced composite 
materials (FRC). Mechanical properties of FRC can be tailored to be equal to those of bone 
by the careful selection of matrix polymer, type of fibres, fibre volume fraction, orientation 
and length. This approach offers an interesting alternative to the use of metallic implants. 
Successful load transfer at bone-implant interface requires proper fixation between the 
bone and implant. One promising method to promote fixation is to prepare implants with 
porous surface. Bone ingrowth into porous surface structure stabilises the system and 
improves clinical success of the implant. 
 
1.3.2 Fibre Reinforced Composites Materials (FRC) 
 
Fibre-reinforced composites (FRC) based on polymer-matrix are nowadays widely 
employed for load-bearing endosseus applications (e.g. hip prosthesis). Aiming the 
mechanical behaviour of native bone, FRC materials can be tuned selecting the proper 
material characteristics, such as matrix polymer, type of fibres, their orientation, length and 
volume fraction. The transfer of the stresses from the matrix to the fibres is endorsed by a 
proper adhesion of fibres to the polymer matrix. Therefore, the interface between fibre and 
polymer matrix is crucial to the fracture toughness and moisture resistance performance of 
the composite (Vallittu, 1996). 
 
1.3.3 FRC Resin Matrices for orthopaedic applications 
 
Polymer matrices for hard tissue applications must respond to several requirements 
as fatigue resistance, low water absorption, resistance to aging in body fluids, 
biocompatibility, dimensional stability, absence of harmful leachable products (e.g. 
residual monomers, activators) and being sterilizable by standard methods (e.g. autoclave, 
dry heat, ethylene oxide, gamma irradiation) (Eschbach, 2000). Recently, non-resorbable 
polymer candidates for bone tissue replacement include polyether-etherketone (PEEK), 
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polysulfone (PSU), polyetherimide (PEI), epoxy resins, polymethyl methacrylate 
(PMMA), and bisphenol A glycidyl methacrylate (Bis-GMA)-based resin systems. 
Thermoset resin systems based on Bis-GMA have been widely used in restorative dentistry 
and recently introduced as a potential matrix candidate for craniofacial and orthopaedic 
applications (Tuusa et al., 2007; Zhao et al., 2009). Polymerised Bis-GMA-based resin 
systems are highly cross-linked, have low polymerisation shrinkage and stiff structure 
(Peutzfeldt, 1997). In some conditions Bis-GMA-based resins can release bisphenol-A 
which has been found to be estrogenic in breast tumour cell culture studies (Olea et al., 
1996). 
 
1.3.4 Fibre reinforcements 
 
Fibre reinforcements for FRC materials mainly include: carbon fibres, glass fibres 
and aramid fibres. Carbon fibres have high resistance to fatigue, creep and wear, are rigid, 
inert and biocompatible reinforcements that are resistant to stretching, but tend to fail by 
buckling in compression. Glass fibre reinforcements have been successfully used in 
restorative and prosthetic dentistry since the late 1990s due to their high tensile and 
compression strength, low extensibility (3.5%), relatively high modulus of elasticity and 
bending strength. PMMA or epoxy resin-based glass fibre-reinforced composites have also 
been developed for orthopaedic devices, such as bone plates (Akeson et al., 1980; 
McKenna et al., 1980). Glass fibres stretch uniformly under stress to the breaking point 
without yielding exhibiting an elastic behaviour. This property enables glass fibres to store 
and release large amounts of energy. Biocompatibility of glass fibres has been studied by 
Väkiparta et al. and no signs of cytotoxicity were found (Väkiparta et al., 2004). Glass 
fibres have adequate mechanical properties and excellent silane coupling agent promoted 
bonding properties with resin matrix. Resorbable silica-based bioactive glass fibres have 
recently been promoted as possible reinforcing materials. Bioactive glasses, exposed to 
tissue fluids, can form a bonding layer of hydroxyl-carbonate-apatite with an underlying 
layer of silica gel (Hench and Paschall, 1973). Partly exposed bioactive glass fibres offer 
osteopromotive effects, resulting in higher interfacial bond strength between implant and 
bone (Marcolongo et al., 1998). However, degradation of bioactive fibres decreases the 
mechanical properties of the composite. Aramid fibres, such as KevlarTM (p-phenylene 
terephtalate), have excellent tensile properties but perform poorly in compression. Thus, no 
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suitable applications for aramid fibres have been found in hard tissue replacement, because 
orthopaedic implants are predominantly loaded in bending (Evans and Gregson, 1998). 
 
1.3.5 Ceramics 
 
Concerning bone and dental TE, the most commonly employed ceramic biomaterials 
are Alumina (Al2O3), Zirconia (ZrO2) and several porous ceramics. These non-metallic 
inorganic materials have a limited range of formulations (Navarro et al., 2008). Both, 
mechanical and biological properties are affected by the microstructure of the material 
which is highly dependent on the applied manufacturing process (maximum temperature, 
duration of the thermal steps, purity of the powder, size and distribution of the grains and 
porosity). Nowadays, one of the most popular application of bioceramics consists on the 
hip prosthesis: femoral heads and acetabular cups made of high density and highly pure 
Alumina. This kind of prostheses exhibited excellent wear rates, excellent corrosion 
resistance, good biocompatibility and high strength. This meant a significant improvement 
in relation to conventional PE cups, responsible for wear debris release that induces a 
foreign body reaction and eventual osteolysis. Nevertheless, ceramic materials components 
suffer from early failures due to their low fracture toughness. Therefore, important efforts 
have been made to improve the material quality by modifying the production processes and 
design requirements. 
 
Hydroxyapatite 
 
In the last twenty years, much attention has been paid to hydroxyapatite (HAp). This 
is a ceramic material essentially composed of phosphorus and calcium. Its synthetic 
formulation – Ca10(PO4)6(OH)2 – resembles with the crystalline bioapatite mineral which 
constitutes 45% by volume, 65% by weight of the mineral fraction of human bone (Petit, 
1999; Tomoda et al., 2009; Ye et al., 2009). HAp powder has been used since 1920 with 
the aim of promoting bone consolidation (Jaffe and Scott, 1996). This crystalline molecule 
was firstly used as a coating for metallic implants in order to improve the osteoconductive 
and osteointegrative properties of the prostheses (Arnould et al., 2010; Faeda et al., 2009; 
Borsari et al., 2009). The application to ostearticular implants demonstrated that implants 
of titanium coated with HAp made possible an excellent bone fixation. 
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HAp is well known to be biocompatible, bioactive, osteoconductive, non-toxic, non-
inflammatory and non-immunogenic agent. For all these reasons, HAp became an essential 
compound of bone implants, cements and scaffolds. Several papers have been published on 
the role of HAp in orthopaedics applications (Turco et al., 2009; Wang et al., 1998; 
Tomoda et al., 2009; Bonfield et al., 1981; Marra et al., 1999; Oliveira et al., 2006; Ramay 
and Zhang, 2003). Moreover, HAp has been used as an adsorbent during chromatography 
for purification and separation, since the surfaces of HAp have high adsorption ability for 
many substances. Therefore, HA has been considered as carriers of protein or antimicrobial 
drugs. Adsorption of proteins onto HAp and slow release from HAp have widely studied 
(Tomoda et al., 2009). Besides adsorption abilities, the surface features of nano-sized HAp 
have been investigated for the significant role of its unique functional properties of high 
surface area to volume ratio which is considered fundamental for cell-biomaterial 
interaction (Murugan and Ramakrishna, 2004). For this reason more interest has been 
focused on new formulations of synthetic HAp which led to crystals or aggregates in the 
range of the nanometric scale. 
Recently, a great attention has focused on the composites of nano-hydroxyapatite 
(nHAp) in conjugation with natural polymers and synthetic polymers (Turco et al., 2009; 
Bonfield et al., 1981; Di et al., 2002; Jarcho, 1981; Mathieu et al., 2006; Oliveira et al., 
2006; Wang et al., 1998; Weir et al., 2006). 
 
1.3.6 Biopolymers 
 
Polymers represent the largest class of biomaterials and they are widely used in 
biomedical devices that include orthopaedic, dental, soft tissue and cardiovascular 
implants. The wide variety of natural polymers relevant to the field of biomaterials 
includes both biopolymers derived from plants such as cellulose, sodium alginate and 
natural rubber, and polymers derived from animals such as collagen, glycosaminoglycans 
(GAGs), heparin, hyaluronic acid and deoxyribonucleic acid (DNA) (Cooper et al., 2004). 
In this section, we will consider only the biopolymers exploited for the finality of the 
thesis.  
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Alginate 
 
Alginate (Alg) was first described in 1881, by the British chemist E.E.E. Standford 
(Guelcher and Hollinger, 2006). It is synthesized in large quantities by marine brown algae 
(Phaeophyceae) (Haug et al., 1974), and it can also be synthesized by bacteria belonging to 
the genera Azotobacter and Pseudomonas (Gorin and Spencer, 1966; Govan et al., 1981). 
Alg is an unbranched polysaccharide consisting of the two sugar residues 1-4 linked β-D-
mannuronic acid (M) and α-L-guluronic acid (G) Figure 1A. The monomers are arranged 
in a pattern of blocks along the chain, with homopolymeric regions (M and G-blocks) 
interspersed with regions of alternating structure (MG-blocks) (Haug et al., 1967; 
Smidsrød et al., 1972; Smidsrød, 1974). A strong correlation between structural and 
functional properties exists in Alg. The intrinsic flexibility of Alg in solution increases in 
order MG > MM > GG (Smidsrød et al., 1973), but the viscosity depends mainly on the 
molecular size (Martinses et al., 1991). By contrast, the selectivity for binding of cations 
and the gel forming properties varies strongly with the composition (Smidsrød et al., 1973) 
and sequence (Smidsrød et al., 1972; Smidsrød, 1974). It has been stated that divalent 
cations like Ca2+, Sr2+ and Ba2+ bind preferentially to G-blocks in a highly cooperative 
manner (Kohn and Larsen, 1972). It is this selective binding to Alg witch accounts for its 
gel forming properties. The high selectivity for G-blocks has been explained by the “egg-
box” model by Grant (Grant et al., 1973), based upon the linkage conformations of the 
guluronic residues. The di-axially linked G-residues will form cavities which functions as 
binding sites for the divalent cations, and sequences of such sites form bonds to similar 
sequences in other polymer chains giving rise to the junction zone in the gel network 
Figure 1B and C. 
a) 
 
b) c)
Figure 1: A) Chemical structure of Alg; b) Probable Ca-binding site in a GG-sequence and c) ionic 
cross-linking of two homopolymeric blocks of G-residues by the egg-box model (Grant et al., 1973).  
Adapted from Strand (Strand et al., 2004). 
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Recently, it has been suggested by Donati et al. (Donati et al., 2005) that G-blocks 
are not the only sequences involved in junction formation. Based on experiments with 
polyalternating Alg, mannuronan and Alg rich in G-blocks, it could be extrapolated that 
junction zones in the gel network could occur between MG/MG-blocks and between 
GG/MG-blocks. 
 
Alginate from brown algae is the basis for numerous applications in biotechnology 
and biomedicine, due to its water-binding, viscosity and gel-forming properties (Smidsrød 
and Draget, 1996). At present, Alg gels are being employed in several areas of drug 
delivery and tissue engineering (Wang et al., 2009). Alg represents an attractive material 
for the preparation of “biohybrid organs” and “micro-bioreactors” because its hydrated 
three-dimensional (3D) network allows cells to adhere, spread, migrate and interact with 
other cells (Zimmermann et al., 2001). 3D matrices are broadly used in TE, in particular 
for stem cell culturing, as they have high specific surface area and support high cell density 
growth. Moreover, this kind of matrices allows control over permeability and mechanical 
strength. The 3D structure of matrices has the potential to provide cells a biomimetic 
environment that aims to resemble the in vivo conditions (Ouyang et al., 2007). Alg 
encapsulation system, exploiting the ability to form cross-linked matrices involving the use 
of divalent cations, includes the paramount benefit to be a flexible technology allowing 
variations in concentration of polymer, Alg composition, bead size and cell seeding 
density. Alg-based systems have been widely tested for islet encapsulation and have been 
shown to provide immuno-isolation after the system transplantation, thus prolonging the 
survival of encapsulated islets (Cui et al., 2004; Omer et al., 2005; Wijsman et al., 1992). 
 
1.4 Scaffolds for Bone Tissue Engineering  
 
One of the most important stages of BTE is the design and processing of a porous, 
biodegradable three-dimensional structure called scaffold (Hutmacher et al., 2007). An 
optimal scaffold for BTE applications should be osteoconductive and angiogenic and it 
should serve as a 3D template to provide structural support to the newly formed bone 
through an interpenetrating network of pores to allow cell migration, tissue in-growth and 
vascularisation. Therefore, high porosity, high pore interconnectivity and uniform pore 
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distribution is required (Hutmacher et al., 2000; Hutmacher, 2000; Hutmacher et al., 2007; 
Mourino and Boccaccini, 2009). 
The scaffold is expected to support cell colonization, migration, growth and 
differentiation, to guide the development of the tissue. In parallel with tissue formation, the 
scaffold may undergo degradation through the release of by-products that are 
biocompatible and that can be excreted or subjected to metabolism. In the field of TE that 
can be broadly defined as a strategy to engineer the repair or regeneration of tissue, it is 
clear that the scaffold plays a central role. Reviewing the literature, it can be concluded 
that it is by no means clear what defines an ideal scaffold–cell or scaffold–neotissue 
construct, even for a specific tissue type. Since some tissues perform multiple functional 
roles, it is unlikely that a single scaffold would serve as a universal foundation for the 
regeneration of even a single tissue. In this context it is salutary to recall one of the many 
definitions of biocompatibility of materials, which determines the suitability of a particular 
material, within the context of the functional role played by the materials following 
implantation. The considerations for scaffold design are hence complex and include 
material composition, architecture, structural mechanics, surface properties, degradation 
properties, together with the composition of any added biological components and, of 
course, the changes in all of these factors with time (Hutmacher et al., 2007). For each 
envisioned application, successful constructs will have certain minimum requirements for 
biochemical and physical properties. Scaffolds are required providing sufficient initial 
mechanical strength and stiffness to substitute for the mechanical function of the diseased 
or damaged tissue which the construct aims at repairing or regenerating. The stiffness and 
strength should be sufficient to at least either permit requisite cell seeding of the scaffold in 
vitro without compromising scaffold architecture, or support and transmit forces in an in 
vivo healing site. The scaffold material should be sufficiently robust to not only resist 
changes in shape as a result of the introduction of cells into the scaffold, each of which 
would be capable of exerting tractional forces, but also the wound contraction forces which 
will be invoked during tissue healing in vivo Figure 2.  
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Figure 2: Overview of scaffold material resorption strategy and bone regeneration and remodelling 
(Hutmacher et al., 2007). 
 
However, during the in vivo phase, external and internal fixation systems or other 
supports or restrictions on patient activity in early-stage recovery may reduce such 
mechanical roles of the intended scaffold. Marrow from a bone defect site has been shown 
to supply the osteogenic progenitor cells that lead to bone repair. However, the 
surrounding tissues may also be a significant source of these important cells and the 
nutrients needed to generate new vascularised bone. Populations of multipotent 
mesenchymal stem cells have been shown to reside within the fibrous connective tissue 
compartments of many tissues and organs, including muscle. Furthermore, it is accepted 
that the periosteum contains quiescent self-renewable osteogenic progenitor stem cell 
populations that can generate new bone. Therefore, the surrounding tissues may play a 
significant role in bone regeneration by providing critical precursor cells and a neovascular 
network to the defect site. In addition, the importance of maintaining the space around 
bone defects is well understood. If the soft tissue can be kept from filling the space, bone 
will have the opportunity to grow into in the protected empty space. Successful bone 
regeneration can be achieved when a high-strength and biodegradable composite scaffold 
with a fully interconnected architecture is used to maintain the space of a critical size 
defect and acts at the same time as an internal fixation device Figure 3. 
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Figure 3: Schematic representation of a bone regeneration process by means of a fully interconnected 
biodegradable scaffold. Note that patient still needs to be immobilized for a certain period of time in 
such a treatment concept (Hutmacher et al., 2007) 
 
The maintenance of sufficient structural integrity is thus critical, more so since the 
cell and tissue remodelling is important for achieving stable biomechanical conditions and 
vascularisation at the host site. The degree of remodelling depends on the tissue itself 
(cancellous bone 3–6 months; cortical bone 6–12 months) and its host anatomy and 
physiology. The scaffold architecture has to allow for initial cell attachment and 
subsequent migration into and through the matrix and for mass transfer of nutrients and 
metabolites, and provide sufficient space for development and later remodelling of the 
organized tissue Figure 2. In vitro, lower porosity stimulates osteogenesis by suppressing 
cell proliferation and forcing cell aggregation. In contrast, in vivo, higher porosity and pore 
size result in greater bone ingrowth. However, this trend results in low mechanical 
properties, thereby setting an upper functional limit for pore size and porosity. Based on 
early studies, the minimum requirement for pore size was considered to be approximately 
100 µm, due to cell size, migration requirements and transport. Because of vascularisation, 
pore size has been shown to affect the progression of osteogenesis. Small pores favour 
hypoxic conditions and induce osteochondral formation before osteogenesis occurs. In 
contrast, scaffold architectures with larger pores rapidly become well-vascularised and lead 
to direct osteogenesis. In more recent in vitro and in vivo studies, pore sizes and pore 
interconnections >300 µm are recommended for sufficient vascularisation of the tissue-
engineered graft (Hutmacher et al., 2007; Zhang and Ma, 1999). In addition to these 
essentials of morphology and geometry, a construct must possess surface properties which 
are most favourable for the attachment and migration of cell types of interest in an 
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applicable 3D structure. The external size and shape of the construct must also be 
considered; especially if the construct is customized for an individual patient (Hutmacher 
et al., 2000; Hutmacher, 2000). In addition to considerations of scaffold performance based 
on a holistic tissue-engineering strategy, practical considerations of manufacturing arise. 
For clinical applications, it must be possible to manufacture the scaffold in a reproducible, 
controlled fashion at an economic cost and speed. The manufacturing process might be 
required to accommodate the presence of biological components; it may be necessary to 
allow cell seeding or the incorporation of biomolecules, which may be soluble or heat-
labile. A review of the current bone engineering literature suggests that the scaffolds 
should fulfil a range of minimal requirements (Zeltinger et al., 2001; Karande et al., 2004; 
Karageorgiou and Kaplan, 2005; O'Brien et al., 2005). The repair and regeneration of 
musculoskeletal tissues remains a demanding application, particularly of bone, where 
scaffolds need to have a high elastic modulus in order to provide temporary mechanical 
support without showing symptoms of fatigue or failure, to be retained in the space they 
were designated for and to provide the tissue with adequate space for growth, (Brekke and 
Toth, 1998). Moreover, bone is able to remodel in vivo under physiological loading 
(Hillsley and Frangos, 1994). Based on these biological processes, it is a requirement that 
the degradation and resorption kinetics have to be controlled in such a way that the 
bioresorbable scaffold retains its physical properties for at least 3–6 months (e.g. 1–3 
months for cell culturing and 1–3 months in situ). Thereafter, the scaffold matrix can start 
losing its mechanical properties and should be metabolized by the body without a foreign 
body reaction after 12–18 months (Hutmacher, 2000). The mechanical properties of the 
bioresorbable 3D scaffold–tissue construct at the time of implantation should match that of 
the host tissue as closely as possible. It should possess sufficient strength and stiffness to 
function for a period until in vivo tissue ingrowth has replaced the slowly vanishing 
scaffold matrix Figure 2. Mechanical loading may directly affect the degradation 
behaviour; studies show that poly(D,L-lactide-co-glycolide) (PLGA) matrix under cyclic 
compressive loading leads to changes in surface deformation and morphology, and that 
compressive loading initially collapses and stiffens the polymer matrix. The decrease in 
molecular weight is slowed down due to the reduction of surface area from hydrolysis, 
until the matrix architecture no longer accommodates the mechanical loading and begins to 
lose its integrity. In the case of constructs which are subjected to extensive in vitro culture 
and implanted in a partially developed state, the intrinsic mechanical properties of the 
scaffold architecture guide cell proliferation and differentiation only up to the phase where 
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the premature bone or cartilage construct is placed in a bioreactor or is transplanted. The 
degradation and resorption kinetics of the scaffold are designed to allow the seeded cells to 
proliferate and secrete their own ECM in the static and dynamic cell-seeding phase (weeks 
1–4), while the polymer scaffold gradually vanishes, leaving sufficient space for new cell 
and tissue growth. The physical support by the 3D scaffold is maintained until the 
engineered bone or cartilage has sufficient mechanical integrity to support itself. However, 
as the scaffold matrix degrades, contractile forces developed by the differentiating tissue 
can result in stresses which result in a significant decrease in the size of the construct 
compared to the size of the original scaffold. The challenge for the in vitro-grown 
cell/tissue construct is to produce an implant with similar mechanical properties to those of 
the host tissue. 
 
1.4.1 Scaffold Morphology and Design 
 
The “design” of skeletal structures must take in account that, in order to make the 
most efficient use of materials, stresses have to be evenly distributed (Hutmacher et al., 
2007). From this principle it would be expected that, for a given material (e.g. cortical and 
cancellous bone), structures would be designed in such a way as to produce approximately 
equivalent stresses which are compatible with the strength of the material. Biewener 
(Biewener, 1989) showed that this was the case for limb bones, with stresses during normal 
locomotion being very similar in a range of species across length scales. More elaborate 
examples are seen in the trabecular structure of the human hip bones, where the struts of 
cancellous bone are aligned with the principle stress directions to make most efficient use 
of the structural members. When a seeded scaffold is implanted with no or minimal in vitro 
incubation, the physical scaffold structure supports the polymer–cell–tissue construct from 
the time of cell seeding up to the point where the hard tissue transplant is remodelled by 
the host tissue (Hutmacher, 2000). In the case of load-bearing tissues, such as articular 
cartilage and bone, the scaffold must also provide sufficient temporary mechanical support 
to withstand in vivo loading. In such cases, the material must be selected or designed to 
have a degradation and resorption rate such that the strength of the scaffold is retained until 
the tissue-engineered transplant is fully remodelled by the host tissue and can assume its 
structural role. Gibson and Ashby classified porous solids into two general groups: foams 
and honeycombs, the honeycomb consisting of a regular two-dimensional array of 
polygonal pores, each defined by a wall shared between adjacent pores. The pores are 
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packed in planar arrays like the hexagonal cells of a honeycomb. The ASTM terminology 
for porous materials is similar and is classified into three groups: interconnecting (open 
pores), non-connecting (closed pores), or a combination of both. When the pores are open, 
the foam material is usually drawn into struts forming the pore edges. A network of struts 
produces a low-density solid with pores connecting to each other through open faces. 
When the pores are closed, the network of interconnected plates produces a higher-density 
solid. The closed pores are sealed off from adjacent neighbours. It was found that the 
mechanical properties of a porous solid depended mainly on its relative density, the 
properties of the material that made up the pore edges or walls and the anisotropic nature, 
if any, of the solid. Given that most constructs will require a high degree of porosity to 
accommodate mass transfer and tissue development, the volume fraction of the scaffold 
will necessarily be low. In all but the most biomechanically challenging applications, it is 
likely that the test will be to achieve sufficient stiffness and strength in a highly porous 
structure to provide adequate mechanical integrity. A great number of other currently 
applied scaffold designs use fast-degrading polymers combined with a high-porosity 
matrix (90%). These types of matrix do not possess the structural stability to be applied in 
the reconstruction of bone defects that are medium to large and are load-bearing (Zhou et 
al., 2007). Scaffold–cell construct designs consisted of a mechanically stable structural 
framework fabricated from a slow-degrading polymer. Besides mechanical stability, 
another important property of this construct is to support 3D tissue development and 
progenitor cell differentiation within the honeycomb matrix architecture by using a 
biomimetic hydrogel as a temporary cell carrier. Sittinger et al. (Sittinger et al., 1999) were 
among the first to study the potential of osteogenic differentiation of cells seeded on to 
scaffolds made by using a textile technology; non-woven fleece structures were shown to 
have a porosity of more then 95%, be biocompatible and bioresorbable, provided high 
internal surface areas for cell attachment and proliferation. 
 
1.4.2 Scaffold Materials  
 
A wide variety of both natural and synthetic materials are being investigated for the 
design and construction of scaffolds for bone tissue engineering (Hutmacher et al., 2007). 
These include: naturally occurring polymers, e.g. alginate, gelatine, agar, fibrin or 
collagen; synthetic bioresorbable polymers, e.g. PGLA, polycaprolactone (PCL) and 
porous ceramics, such as bioactive glass, calcium phosphate structures and naturally 
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occurring ceramics, such as coral. The considerations of mechanical properties and 
degradation behaviour that have been discussed for the scaffold structure clearly bias 
materials selection. In addition, the biological interactions (protein and peptide adhesion, 
cell adhesion, migration, proliferation and differentiation) are primarily a function of the 
surface properties of the scaffold material. Unlike in the 1990s, when scaffold design and 
fabrication were directly based on commercially available bioresorbable implants and 
devices, current approaches widely use a variety of new materials aimed at providing a 
suitable matrix for cellular growth and attachment. The basic spectrum of materials used 
broadly includes both natural and synthetic organic and inorganic materials. 
 
1.4.3 Composite Based Scaffolds  
 
The combination of bioactive ceramics such as calcium phosphates with polymers 
improves the mechanical properties of scaffolds (Hutmacher et al., 2007). A major 
challenge is to get a good chemical and/or physical binding between the polymer and the 
ceramic phase. A composite matrix also enhances the osteoconductive properties of the 
scaffold (Ignjatovic et al., 1999b; Ignjatovic et al., 1999a; Marra et al., 1999). Several of 
these composites are under investigation (Cerrai et al., 1999; Liu et al., 1998; Shikinami 
and Okuno, 1999; Zhang and Ma, 1999). They include natural polymers in combination 
with HAp e.g. Alg-HAp (Turco et al., 2009), collagen–HAp (Liao et al., 2005a; Liao et al., 
2005b), chitosan–HAp (Li et al., 2005) composites and synthetic polymers such as PLA 
(McManus et al., 2005), PLA–Polyethylenglycol (PEG) (Kaito et al., 2005), in 
combination with BAG (Tancred et al., 2001). Composites made of collagen–PLA–HAp 
are also being increasingly considered for use as scaffold materials for bone tissue 
engineering (Liao et al., 2004; Liao and Cui, 2004). Biodegradable polymer composites 
have attracted considerable attention due to their potential applications to orthopaedic 
surgeries for hard tissue repair and reconstruction in order to replace currently used 
materials. Potential problems of biocompatibility in tissue engineering, by applying 
degradable, erodible and resorbable polymer scaffolds may also be related to their 
biodegradability and bioresorbability (Vert et al., 1992). Therefore, it is important that the 
3D scaffold–cell construct is exposed at all times to sufficient quantities of neutral culture 
medium, especially during the period where the mass loss of the polymer matrix occurs; it 
has been reported that a high amount of degradation by-products leads to the death of an 
entire cell culture. The incorporation of β-Tricalcium Phosphate (β-TCP), HAp and basic 
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salts into fast polymer matrix systems, such as PGA and PGA/PLA, produces a 
hybrid/composite material. These inorganic fillers allow the desired degradation and 
resorption kinetics of the polymer matrix to be tailored. The properties of a composite 
material should be designed that that ceramic particles are not only embedded into the 
polymer matrix, but ceramic particles should be also exposed on the surface to improve 
osteoconductivity. In addition, the basic resorption products of HAp or TCP would buffer 
the acidic resorption by-products of the aliphatic polyester and may thereby help to avoid 
the formation of an unfavourable environment for the cells due to decreased pH. 
An interdisciplinary group at the National University of Singapore, in collaboration 
with Temasek Polytechnic, has evaluated and patented the parameters necessary to process 
PCL and PCL composites (PCL–HA, PCL/TCP, etc.) by Fused Deposition Modelling 
(FDM) (Hutmacher, 2000). These so-called first generation scaffolds have been studied for 
more than 5 years in a clinical setting, have been commercialized 
(http://www.osteoporeinternational.com) and have gained Federal Drug Administration 
(FDA) approval. The groups of Schantz J.T. (Schantz et al., 2006) used FDM-fabricated 
PCL scaffolds as burr hole plugs in a pilot study for cranioplasty. The clinical outcome 
after 12 months was positive, with all patients tolerating the implants, no adverse side-
effects reported and good cosmetic and functionally stable cranioplasty observed in all 
cases. Today more then 200 patients received burr plugs, sheets for orbital floor 
reconstruction or other cranioplasties. The second-generation scaffolds produced by FDM 
for bone engineering are based on composites and have been evaluated in vitro and in vivo 
(Zhou et al., 2007). Polymer–calcium phosphate (CaP) composites confer favourable 
mechanical and biochemical properties, including strength via the ceramic phase, 
toughness and plasticity via the polymer phase, more favourable degradation and 
resorption kinetics, and graded mechanical stiffness. In these scaffolds, the ceramic phase 
is homogeneously distributed in the matrix as well as being exposed on the surface. 
Contact angle measurements show that such composite surfaces are more hydrophilic and 
that the degradation kinetics are accelerated three to four fold compared to PCL alone. 
Biochemical advantages include improved cell seeding and enhanced control and/or 
simplification of the incorporation and immobilization of biological factors, such as Bone 
Morphogenetic Proteins (BMPs) (Rai et al., 2004; Rai et al., 2005). Recently the group at 
the National University of Singapore studied PCL–CaP composite scaffolds for cranial, 
osteochondral and spinal fusion in immunocompetent animal models. The reconstruction 
of segmental defects in long bone is a clinical challenge. Multiple surgeries are typically 
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required to restore the structure and function of the affected defect site. In order to 
overcome the current problems of applying scaffolds in high-load bearing areas, 
Hutmacher et al. (Hutmacher et al., 2007) developed a composite scaffold based on a 
poly(L-lactic acid) : poly L, D Lactic acid (PLLA:PDLA) 70 : 30 polymer matrix system. 
This scaffold can act as a carrier of proteins and growth factors, while also supporting the 
load that the bone would normally sustain, until the natural bone can regenerate in its 
place. Work was done to optimize an existing FDM process to cater for processing of this 
high-strength material. The overall goal of the optimization was to increase the porosity of 
the scaffold to 75–80% while at the same time increasing the strength of a previously 
tested prototype design. With this in mind, different designs and composite compositions 
were created and the compressive strength of each design was measured. 
 The use of synthetic or natural polymer matrices with low mechanical properties 
(high porosity) and fast degradation kinetics, results in tissue-engineered grafts with high 
biological activity but poor structural properties, in particular low strength and stiffness. 
Such tissue-engineered grafts can be used in a manner similar to cancellous bone chips, 
e.g. in non-load-bearing applications or in combination with internal or external fixation 
devices. Guan et al. (Guan and Davies, 2004) and Lickorish (Lickorish et al., 2007) have 
reported the use of a composite scaffold for bone tissue engineering by combining 
biodegradable PLGA with bioresorbable CaP cement particles through the process of 
particle fusion and phase separation/particle leaching. The scaffold is characterized by a 
highly interconnected macroporosity, with macropores of 0.8–1.8 mm, porosities of 81–
91% and improved mechanical properties with respect to the polymer alone, producing 
improved dimensional stability over culture times. Navarro et al. (Navarro et al., 2004) 
have reported the development of composites of biodegradable polymers with different 
calcium phosphate ceramics and glasses as scaffolds for applications in bone tissue 
engineering. Phosphate glass particles were incorporated into the PLA polymer and porous 
structures were made. The incorporation of glass particles was shown to have a positive 
effect in the mechanical properties of the foams, where interconnected structures with 
evenly distributed pores and a porosity as high as 97% were obtained. A novel approach to 
forming a polymer–ceramic composite has also been demonstrated combining degradable 
PLGA microspheres and a poorly crystalline CaP synthesized within the microspheres, 
which are then fused together to form a porous 3D scaffold for bone repair, (Khan et al., 
2004). The fabricated scaffold had porous interconnected structures and mechanical 
properties in the range of trabecular bone. Gross et al. (Gross and Rodriguez-Lorenzo, 
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2004) spheroidised salt particles in a flame and sintered them to provide an interconnecting 
salt template which was filled with a carbonated fluorapatite powder and a polylactic 
polymer to produce a composite scaffold. It was shown that a higher pore space is possible 
with the use of spherical and larger salt particle sizes. This technique can produce scaffolds 
with good interconnectivity and be suitable for producing pore size graded bodies. Rizzi et 
al. (Rizzi et al., 2001), in studies of simple PLA–HAp and PCL–HAp mixtures prepared by 
solvent casting onto glass surfaces, showed that cells tended to attach to and bridge 
between surface-exposed HAp particles and that the presence of HAp led to increased cell 
activity. It was concluded that the presence of exposed HAp may provide a means for 
control of cell density on material surfaces. Furthermore, the osteoconductive properties of 
CaP when incorporated into polymer composites have stimulated research into polymer–
ceramic blends and ceramic coatings on polymer matrices for bone tissue-engineering 
applications. HAp/PLLA blends have been made by melting and hot/cold pressing (Ramay 
and Zhang, 2003). It has been observed that the induction of HAp increased the mechanical 
properties and improved the protein adsorption capacity of nHAp (nHAp–PLLA) 
composite scaffolds. These scaffolds of high porosity (>90%) and well-controlled pore 
architectures were prepared using thermally induced phase-separation (TIPS) techniques, 
aimed at better mimicking the mineral components and microstructure of natural bone 
(Wei and Ma, 2004). The preparation and morphologies of 3D porous composites from 
PLGA or PLLA solution and HAp from other groups have shown similar results, where the 
composite foams showed significant improvement of mechanical properties despite 
porosities above 95% (Zhang and Ma, 1999). Similar highly porous PLLA and PLLA–
HAp composite scaffolds prepared with TIPS techniques, when seeded with osteoblastic 
cells and cultured in vitro, showed that the osteoblasts penetrated deep into the PLLA–
HAp scaffolds and were uniformly distributed, and the percentage cell survival in the 
PLLA–HAp scaffolds was superior to that in PLLA scaffolds and showed better 
proliferation and higher expression of bone-specific markers, thus demonstrating good 
osteoinductivity (Ma et al., 2001). Ural et al. (Ural et al., 2000) studied copolymers of 
PCL–PDLA and PCL–PDLA–CaP blends and conclude that the CaP component leads to 
faster degradation kinetics. These findings were confirmed by Marra et al. (Marra et al., 
1999), who showed that addition of CaP to CaP–PCL–PLGA blends increased the 
degradation rate and CaP dominated degradation at higher volume fractions with no 
significant difference between different polymer blends. Studies on 3D HAp–collagen 
composite scaffolds made from biomimetically mineralized collagen exhibited an 
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interconnecting pore structure and elastic mechanical properties. In vivo implantation in the 
subcutaneous tissue showed resorption at 2 months by phagocytosis, and resorption and 
replacement by new bone of many parts of the materials implanted in the defects of the 
long bone was observed at end of 3 months (Yokoyama et al., 2005). Similar synthesized 
collagen-derived gelatine–HAp nanocomposites were investigated for osteoblastic cellular 
responses; the scaffolds retained less crystallized and smaller-sized apatite crystals and a 
more well-developed pore configuration than the conventional ones (Kim et al., 2005). 
PDLLA foams and bioactive glass particles have been used to form bioresorbable 
composite scaffolds; these highly porous PDLLA foams filled with 10 wt% BAG particles 
has been proposed to be highly bioactive and suitable for bone tissue engineering 
(Boccaccini et al., 2003). The addition of increasing amounts of BAG into the polymer 
foams decreased the pore volume. Conversely, the mechanical properties of the polymer 
materials were improved; the presence of the bioactive filler was also found to delay the 
degradation rate of the polymer as compared to the neat polymer foams (Maquet et al., 
2004). Mathieu et al. (Mathieu et al., 2006) developed open cell composite foams 
consisting of bioresorbable PLA and ceramic fillers, HAp or β-TCP by supercritical CO2 
foaming technique. Their internal 3D structure was found to be anisotropic in morphology, 
with pores orientated in the foaming direction, as evidenced by micro-computed 
tomography (µ-CT) analysis. Furthermore, compressive tests confirmed anisotropy in 
mechanical behaviour, with an axial modulus up to 1.5 times greater than the transverse 
modulus. The Davis laboratory reported the development of so-called ‘third generation’ of 
scaffold materials (Lickorish et al., 2007). Their results demonstrate that the addition of a 
CaP thin film to the surface of a macroporous PLGA–CaP composite yields an 
osteoconductive scaffold of higher compressive strength, which also prevents the 
development of a chronic inflammatory response. This three-phase construct overcomes 
both biological and material limitations of previous scaffold material formulations to 
describe a unique, fully resorbable scaffold for use as an alternative to the trabecular bone 
graft. 
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1.5 Methods of investigation in Bone Tissue Engineering  
 
In scaffold-based tissue engineering, scaffold architectural features are studied after 
the design and fabrication process; hence, allowing an assessment of the feasibility and the 
precision level of the process (Ho and Hutmacher, 2006). These architectural 
characteristics would include porosity, pore size, surface area to volume ratio, 
interconnectivity, anisotropy, trabecular thickness, cross sectional area and permeability 
(Lin et al., 2003). The mechanical strength and biological functionality of the scaffold are 
influenced by these characteristics. Various techniques can be used to evaluate them and 
they would include theoretical assessment, scanning electron microscopy (SEM) analysis, 
flow and mercury porosimetry, gas pycnometry and adsorption. Researchers have only 
recently employed micro-computed tomography (µ-CT) in the study of scaffolds. Gas 
adsorption and flow porosimetry have potential applications in the assessment of scaffold 
architecture; however, there is yet to be any report of their usage in the current literature. 
As one goes about selecting a suitable technique in characterizing scaffolds, the associated 
virtues and pitfalls of each technique should be scrutinized. Sometimes a combination of 
techniques is required so as to achieve an in depth study of the scaffold properties. 
However, the most attractive option is a single technique which is non-destructive, yet 
capable of providing a comprehensive set of data. It appears that µ-CT can potentially 
fulfil this role although it is not without limitations. When it was first developed, micro-CT 
was used extensively in the study of trabecular structures (Muller et al., 1994) and 
important structural data can be derived after scanning the specimens.. 
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1.6 Architectural and Structural Parameters  
 
Molecular transport in tissue engineered constructs is dependent on vasculature 
growth and diffusion (Ho and Hutmacher, 2006). At the implantation sites, vasculature 
provides the main mode of transport, while for in vitro culture, diffusion would be the sole 
approach. In order to ensure the survivability of the cells, the pore network has to be 
optimized so as to facilitate molecular transport (Karande et al., 2004). Molecular transport 
would include the exchange of oxygen, nutrient, metabolic wastes and molecular 
signalling. These biochemical exchanges are essential for cell proliferation and migration. 
When molecular transport is hampered due to poor diffusion, cell—scaffold constructs 
exhibit peripheral cellular growth while the interior of the construct undergoes necrosis 
(Ishaug-Riley et al., 1997). In the light of this, scaffolds are evaluated against a series of 
properties Table 1, so as to assess the ease of diffusion within the scaffold (Hildebrand et 
al., 1999). Moreover, researchers are able to gauge the mechanical properties and cellular 
response of the scaffold from these characteristics. One of the key properties that is widely 
discussed in the literature is porosity (Zein et al., 2002; Schantz et al., 2002; Meinel et al., 
2004). Porosity would determine cell seeding efficiency, diffusion and mechanical strength 
of the scaffold. High porosity and high surface area to volume ratio are required for 
uniform cell delivery, cellular attachment and neo-tissue in growth (Kim and Mooney, 
1998; Mooney et al., 1996). In a landmark study by Langer et al., a porosity of 90% was 
recommended for optimum diffusive transport within a cell–scaffold construct under in 
vitro conditions (Freed et al., 1994). However, scaffolds with such a high porosity would 
possess very low mechanical strength. In creating scaffolds for load bearing tissues such as 
bone and cartilage, mechanical integrity is a concern, hence there must be a compromise 
between the porosity and mechanical properties of the scaffold (Hollister et al., 2002). 
Studies on scaffold design have revealed that besides porosity, other factors such as pore 
interconnectivity and permeability affect molecular transport. The scaffold permeability 
describes the size of the pore interconnections and this influences the ease at which a fluid 
flows through the pore network.  A highly porous scaffold may have non-interconnected 
pores, thus lowering the diffusion efficiency. Suh et al. cultured chondrocytes on scaffolds 
of equal porosity but of varying degrees of interconnectivity. They observed superior cell 
attachment and proliferation in scaffolds with highly interconnected pores (Suh et al., 
                                                               Introduction                                                              a 
-33- 
2002).. Besides interconnection, permeability is also dependent on pore orientation, pore 
size and distribution (Ma and Zhang, 2001).  
 
 Characteristics Formulae/elaboration 
1. Total Volume (TV) Volume of the sample 
2. Bone Volume (BV) Volume of the solid phase of the sample 
3. Bone Surface (BS) Surface of the solid phase of the sample 
4. Porosity Porosity = 1 – (BV/TV) 
5. Trabecular Thickness (Tr.Th) A measure of the thickness of the scaffolds’ walls 
6. Trabecular Separation (Tr.Sp) Average diameter of the pores 
7. Bone Surface to Bone Volume A specific measure of the surface of the solid phase 
8. Connectivity Density Number of the walls per unit length 
 
Table 1: Fundamental architectural and structural characteristics of scaffolds (Hildebrand et al., 
1999). 
 
Other parameters which are used to assess the functionality of the scaffold would 
include surface area and pore size. A large surface to volume ratio would assist cellular 
adhesion. Moreover, pore sizes should be sufficiently large so as to encourage cellular in 
growth. Depending on the tissue type (soft or hard tissues), some of the tissue engineered 
constructs must possess sufficient mechanical strength so as to withstand loading, thus 
trabecular thickness, anisotropy and the cross sectional area of the scaffold would be of 
interest. In the creation of scaffolds, two methodologies are observed. Researchers would 
determine the design of the scaffolds first and a selection of a fabrication technique which 
satisfies the requirements follows. In the second approach, a fabrication method is chosen 
and from that platform, scaffold designs are optimized. The determination of architecture 
properties is crucial in both methodologies, thus it is important to have an understanding of 
the efficacies associated with each scaffold evaluation method so as to select the suitable 
assessment technique. It should be noted that the only some of the parameters are of 
emphasis and this would usually depend on the scaffold design.  
 
1.7 Micro Computed Tomography  
 
Feldkamp et al. pioneered micro-CT when they developed an X-ray-based 
microtomographic system to analyze trabecular samples at a spatial resolution of 50 mm 
(Feldkamp et al., 1989; Ho and Hutmacher, 2006). Since then, micro-CT had been used 
extensively in the study of trabecular architecture (Ruegsegger et al., 1996) and there are 
increasing applications of it in other areas. Its popularity can be attributed to its ability to 
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provide precise quantitative and qualitative information on the 3D morphology of the 
specimen. The interior of the specimen can be studied in great detail without resorting to 
physical sectioning and using toxic chemicals. Moreover, after scanning, the intact samples 
can be subjected to other tests, therefore resolving the problem of sample scarcity. As 
researchers began to recognize the potential of this radiographic technique, various 
biomedical applications are being explored which would include the assessment of 
scaffolds structure, tissue regeneration (Verna et al., 2002) and vasculature networks 
(Bentley et al., 2002; Jorgensen et al., 1998; Ortiz et al., 2000). In micro-CT scanning, the 
specimen is computed as a series of 2D slices which are irradiated from the edges with X-
rays. Upon transversing through the slice, the X-rays are attenuated and the emergent X-
rays with reduced intensities are captured by the detector array. From the detector 
measurements, the X-ray paths are calculated and the attenuation coefficients are derived. 
A 2D pixel map is created from these computations and each pixel is denoted by a 
threshold value which corresponds to the attenuation coefficient measured at a similar 
location within the specimen. As the attenuation coefficient correlates to the material 
density, the resultant 2D maps reveal the material phases within the specimen. The quality 
of the 2D maps is dependent on the scanning resolution which ranges from 1 to 50 mm 
(Feldkamp et al., 1989; Weiss et al., 2003). At high resolutions, intricate details are 
imaged, however more time is required for high resolution scanning and the resultant large 
data set poses a challenge for data storage and processing. 3D modelling programs such as 
Image Pro Plus (Media Cybernetics) stacks the 2D maps to create 3D models. As 
computation is inherent in this technique, the selection of software and hardware facilities 
would influence the efficiency and effectiveness of this radiographical assessment. The 
recent use of µ-CT in scaffold research enabled morphological studies to be carried out, 
yielding comprehensive data sets. From the scan data, measurements of the scaffold 
material volume, surface area, trabecular width and pore sizes were taken. Using threshold 
inversion, the pore network was visualized and the pore interconnectivity was studied (Ho 
and Hutmacher, 2006).  
Mechanical tests are conducted so as to ascertain the mechanical properties of the 
scaffold, however most of these tests are destructive; hence, a non-destructive method is 
sought. Researchers have considered finite element modelling (FEM) as an alternative to 
mechanical testing as simulations can be carried out via computations. FEM requires the 
input of precise 3D structural and architectural information of scaffolds, which can be 
obtained from µ-CT scans (Jaecques et al., 2004). Similarly, diffusion patterns in scaffolds 
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can also be investigated through fluid flow studies which are simulated via FEM. Scaffolds 
with intricate interior structures can be scrutinized using µ-CT, as any spatial location of 
the architecture can be digitally isolated out. This is crucial for scaffolds that exhibit 
different geometric layouts at different spatial locations. Micro Computed Tomography 
possesses this key advantage over other techniques such as mercury and flow porosimetry. 
Within the digitally excised scaffold cube, scaffold material volume and surface area are 
measured, thus allowing the calculation of porosity and surface area to volume ratio. 
Three-dimensional imaging allows a close up view of any specific location, thus the 
observation of pore shape and the measurement of pore size and trabecular thickness can 
be conducted in these close ups. Scaffold anisotropy is evaluated via algorithms (Lin et al., 
2003) and the cross-sectional area can be measured from the 2D slice images. By inverting 
the threshold, a negative image is created which captures only the scaffold pores. By 
measuring the total and the interconnected pore volumes, interconnectivity is derived (Ho 
and Hutmacher, 2006). In studying scaffold permeability, a suitable visualization program 
needs to be selected. As µ-CT employs penetrative X-rays, closed pores can be imaged. 
The flexibility of micro CT analysis allows the evaluation of foams, textiles and nanofiber 
scaffolds. There are associated concerns despite of the numerous advantages of using µ-
CT. Image thresholding is a crucial step that has to be executed prior to 3D modelling and 
it affects the subsequent analysis and visualization (Meinel et al., 2004; Duvall et al., 
2004). In the conventional approach, the thresholding range is selected via histographics 
and visual estimation and the problem arises when the scaffold composes of multiple 
materials whose thresholding ranges overlap and this renders the digital separation of these 
materials a difficult task. Moreover, as polychromatic X-ray beams are used in micro CT, 
the lower energy rays would be readily attenuated by the sample resulting in a high 
exposure at the centre of the scaffold. This effect is known as beam hardening and as a 
result thresholding is no longer dependent solely on radiodensity but also on the specimen 
size (Verna et al., 2002; Bonse and Busch, 1996). Micro CT analysis is not suitable for 
scaffolds containing metals as X-rays are heavily attenuated by these metals. The presence 
of metals results in dark and bright grainy artifacts which obscure important details in the 
scan images (Ho and Hutmacher, 2006). As µ-CT is a relatively new technology, improved 
algorithms and setups are anticipated, thus resolving such imaging errors. 
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2. AIMS OF THE STUDY 
 
With the rapid progresses of the materials used in the field of Bone Tissue 
Engineering, the obsolescence of the metallic prostheses employed in the orthopaedic 
framework has become evident. The shortcomings of this kind of devices could be 
gathered in two major domains: a) their high mechanical properties, far away from the 
ones of the native bone, which cause bone resorption and consequent failure of the 
implant; b) the lack of osteointegration with the boundary osseous tissue which not 
promote incorporation of the prosthesis in the defect’s site. The drawbacks of the metallic 
implants could be exceeded by the usage of a new generation of osseous implants able to 
interact with the native bone and to guarantee a perfect matching between the mechanical 
properties of the bone tissue and the ones of the prosthesis. 
This study aimed to develop osteoconductive coatings, called scaffolds, for bone 
prosthesis based on fibre-reinforced polymethacrylate resins. 
The design of the scaffold’s prototype was achieved assessing:  
- the optimization of the scaffold’s casting procedure; 
- the interlocking of the scaffold to the dense load-bearing core made of composite 
material. 
 
The scaffold was conceived as a structure which must mimic the architectural 
features of the trabecular bone, supporting cell adhesion and bone ingrowth. Moreover the 
temporary feature of the coating was taken into account by tuning the dissolution of the 
scaffold in biological environments. In parallel a deep characterization of the obtained 
manufactured products were performed. The characterization of the scaffold’s structure 
allowed to obtain quantitative features of the porous 3D network obtained. These 
investigations were conducted by means of physical-chemical examinations and biological 
in vitro and in vivo testing. 
 
The results obtained in this work allowed to retain the devices here developed as 
promising for orthopaedic applications. 
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3. MATERIALS AND METHODS 
 
3.1. Materials 
 
Sodium alginate samples isolated from Laminaria hyperborea stipe were provided 
by FMC Biopolymer (Norway) (MW=1.3x105, FG =0.69; FGG=0.56). HAp powder was 
from Fluka (USA). Dulbecco’s modified Eagle’s medium (DMEM), McCoy's 5a Medium 
Modified, fetal bovine serum (FBS), penicillin, streptomycin, trypsin/ EDTA solutions, 
phosphate-buffered saline (PBS), glutamine, N-(2-Hydroxyethyl)piperazine-N′-(2-
ethanesulfonic acid) sodium salt (HEPES) and D-Gluconic acid δ-lactone (GDL) were 
purchased from Sigma (USA). CellTiter Aqueous One Solution cell proliferation Assay kit 
(MTS assay) was from Promega (USA). E-glass fibre veil (100 g/m2); lot number GFT-
56G8-100 was provided by Ahlström (Karhula, Finland). Bisphenol A 
glycidylmethacrylate (Bis-GMA) CAS Number 1565-94-2, triethyleneglycol 
dimethacrylate (TEGDMA) CAS Number 109-16-0 were purchased from Aldrich. 
Camphorquinone (CQ) CAS Number 10373-78-1 and 2-dimethylamino ethylmethacrylate 
(DMAEMA) CAS Number 2867-47-2, Benzoyl Peroxide (BPO) CAS Number 527909 
were purchased from Fluka Vitamin E (Vit E) CAS Number 10191-41-0 was purchased 
from Supelco.  
All other chemicals were of analytical grade. 
 
3.2. Polysaccharide Solutions 
 
Alginate solutions were obtained diluting a batch solution of Alg 4% in 1x buffer 
solution. 1x buffer solution was prepared mixing HEPES buffer with NaCl with a final 
concentration of 10mM and 150mM respectively and the pH was adjusted to 7.4. 
 
3.3. Texture analysis 
 
The concept of texture is strictly related to the human vision behaviour and it appears 
to depend upon three ingredients (Hawkins, 1970): (i) some local order repeated over a 
region which is large in comparison to the order's size, consisting of (ii) nonrandom 
arrangement of elementary parts that are (iii) roughly uniform entities having 
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approximately the same dimensions everywhere within the textured region. Although this 
description of texture seems perceptually reasonable, it does not immediately lead to a 
quantitative textural measure. Various approaches have been proposed in literature to attain 
this aim (Pratt, 2007). In this work a distinction is made among three different approaches: 
a first one in which the image histogram is analyzed, a more refined one based on the 
analysis of a suitably created matrix, called grey level co-occurence matrix (GLCM), and 
the fractal approach. 
 
3.4. Histogram analysis 
 
A first approach on texture analysis is based on statistical properties of the intensity 
histogram. The normalized intensity histogram of an image is the discrete function  
n
n
ip i=)(
 
where ni represents the number of pixels having intensity i = 0, 1,..., L-1, with L the 
number of possible intensity levels and n is the total number of pixels in the image. 
Starting from p(i) the following parameters were adopted as simple descriptors of texture 
(Gonzales et al., 2003): 
1) Mean (a measure of average intensity) 
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2) Standard deviation (a measure of average contrast) 
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3) Smoothness 
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measures the relative smoothness of the intensity in the image. S is equal to 0 for an 
image of constant intensity and approaches to 1 for images with large average contrast. 
4) Uniformity 
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measures the grey levels variability and it has a maximum if all grey levels have the 
same value. 
5) Entropy (a measure of randomness) 
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3.5. GLCM approach 
 
Haralick et al. (Haralick et al., 1973) have proposed a number of more refined 
textural features based on the grey level co-occurrence matrix (GLCM) concept. The 
GLCM of an image is an estimate of the second-order joint probability q(i,j) of the 
intensity values of two pixels a distance d apart along a given direction θ, i.e. the 
probability that a pixel with grey level i has the same intensity value of a pixel with grey 
level j. This joint probability takes the form of a square matrix with row and column 
dimensions equal to the number of discrete grey levels (256 levels for 8-bit images) in the 
image being examined. If an intensity image is entirely flat (i.e. contains no texture), the 
resulting GLCM should be completely diagonal. As the image texture increases (i.e. as the 
local pixel intensity variations increase), the off-diagonal values in the GLCM become 
larger (Bharati et al., 2004). 
Haralick et al. (Haralick et al., 1973) suggested to use GLCMs calculated from four 
displacement vectors with d = 1 and θ ={0°, 45°, 90°, 135°}, respectively. In this work, 
only one GLCM was calculated using a single displacement vector with d = 1, as originally 
proposed by Haralich et al., and θ = 0°, i.e. the horizontal right adjacent pixel (sometimes 
called the “east” pixel) was used. Because of the quite isotropic nature of the texture being 
considered a single angle was found to be adequate. Starting from q(i,j) the following 
parameters (Haralick and Shapiro, 1991) were used for textural description: 
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represents a measure of average difference between the reference pixel and the 
neighbor pixel in the whole image. Contrast C ∈ [0, (L-1)2] where the case C = 0 occurs in 
the presence of a constant image. 
2) Correlation 
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where µr, µc, σr, and σc are the means and standard deviations computed separately on 
rows and columns of the matrix as:  
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is a measure of how the reference pixel is correlated to neighbor pixel. Correlation R 
∈ [-1,1] is equal to 0 if no correlation is present while R = ± 1 means perfect correlation.  
 
3) Energy 
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defines the energy (or uniformity or second angular moment). The energy E ∈ [0,1] 
is equal to 1 for a constant image. 
 
4) Homogeneity 
∑∑−
=
−
= −+=
1
0
1
0 1
),(L
i
L
j ji
jiqH
 
is a measure of how much elements of the matrix are close to the diagonal of the 
GLCM. The homogeneity H ∈ [0,1] is equal to 1 for a diagonal GLCM. 
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3.6. Fractal approach 
 
Since the notion of texture relies on the existence of some “order”', it is also possible 
to utilize the fractal theory, proposed by Mandelbrot (Mandelbrot, 1982) for the study of 
fractal objects. In fact, a fundamental property of this mathematical object concerns the 
auto-similarity, for which the structure of the object is replicated in the same way at 
different scale. This property can be characterized in terms of fractal dimension that 
represents a measure of the “roughness” of an object. When it is used as textural descriptor 
it can be interpreted as an index of “coverage”: high values for fractal dimension imply the 
presence of a texture that covers the image leaving few and small “void” areas. Different 
methods has been proposed for the estimation of the fractal dimension for both binary and 
grey-scale images (Smith, Jr. et al., 1996).  
In this work the Triangular Prism Surface Area method (TPSA) was used. First 
proposed by Clarke (Clarke, 1986) and further revisited by De Santis et al. (De Santis et 
al., 1997), the TPSA method could be considered as one of the most effective for the 
estimation of fractal dimension of grey-scale images (Smith, Jr. et al., 1996). The TPSA 
method derives a relationship between the surface area of triangular prisms defined by the 
grey values of the image and the step size (also called the ruler) of the grid used to 
measure the prism surface area. For each step in a series of step sizes, a series of triangular 
prisms are constructed by locating them successively at the center of squares whose side is 
the step size. The height of the prism at the corner is defined by the pixel grey value. The 
average of the pixel values, in the image lattice, located at the four corners of the prism 
becomes the height of the apex of the prism which is placed at the common node of the 
four pixels. This defines the four triangular surfaces constituting the faces of the prism. In 
the original algorithm the logarithm of the surface area is linearly regressed against the 
logarithm of the square of the step size. In the approach of De Santis et al. (De Santis et al., 
1997) a virtual square with side 
iσδ =  
(where σi is the real upper surface of the i-th prism) is used and the mean value of all 
the δi is assumed as mean ruler. The fractal dimension D is then calculated as D = 2 - B, 
where B is the slope of the regression. 
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3.7. Polysaccharides Microcapsules  
 
Polysaccharide microcapsules were obtained by dripping the polymer (Alg o binary 
mixture of Alg/Ctl) into the gelling solution (50mM CaCl2, 150mM NaCl, 10mM HEPES, 
pH 7.4). The droplet size was controlled by use of a high-voltage electrostatic bead 
generator (Strand et al., 2002) (5 kV, 10 mL/h, steel needle with 0.4 mm outer diameter, 
1.7 cm distance from the needle to the gelling solution). The gel beads obtained were 
stirred for 30 min in the gelling solution prior to use. 
 
3.8. Low Field NMR Measurements 
 
Low field Nuclear Magnetic Resonance (NMR) characterization was performed by 
means of a Bruker Minispec mq20 (0.47 T). Transverse relaxation time (T2) measurement 
was made according to CPMG (Carr-Purcell-Meiboom-Gill) sequence with 90-180° pulse 
separation of 1 ms (number of scans 3; recycle delay 5 s; 3 replicates were averaged for 
each sample.). T2 distribution was determined by first fitting experimental relaxation data 
by a sum of exponential functions (S) whose number minimized the product χ2Np, where χ2 
is data fitting while Np is the number of model parameters used (each exponential function 
considered involves two parameters: the pre-exponential factor, Ai, and relaxation time 
T2i). Then, the continuous relaxation time distribution derives from the iterative solution of 
a linear system of equation whose unknowns represent the desired distribution and whose 
right-hand side column vector represents S(tj) (tj is the generic instant time). The system 
matrix coefficient derives from S(tj,T2) integration (trapezoid rule) on the continuous 
relaxation time distribution (T2min - T2max).  
 
3.9. Rheological Measurements 
 
Hydrogel rheological characterization was performed, at 25 °C, by means of a 
controlled stress rheometer Haake Rheo-Stress RS150, with, as measuring device, a 
shagreened plate and plate apparatus (PP35 TI: diameter Ø=20 mm; gap between plates = 2 
mm). This kind of device was used in order to avoid possible slippage phenomena at the 
wall. The linear viscoelastic range was determined by means of a stress sweep test 
consisting in the measuring of elastic (G′) and viscous (G′′) modules variation with 
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increasing deformation (γ) being the solicitation frequency f = 1Hz (ω = 2πf = 6.28 rad/s). 
The hydrogel mechanical spectrum was determined according to a frequency sweep test 
consisting in the measurement of elastic (G′) and viscous (G′′) modules variation with 
decreasing pulsation ω at constant deformation γ = 0.01 (well within the linear viscoelastic 
range). 
 
3.10. Synthesis of nano-Hydroxyapatite 
 
Preparation of nHAp was achieved following the indications reported elsewhere 
(Murugan and Ramakrishna, 2004). Briefly, nHAp was prepared by wet chemical method 
using CaCl2 (Sigma, USA) and (NH4)2HPO4 (Sigma, USA) as Ca and P precursors, 
respectively. To precipitate stoichiometric nHAp, 0.3 M aqueous solution of (NH4)2HPO4 
was slowly added drop by drop to 0.5 M aqueous solution of CaCl2. The rotation speed of 
stirrer was adjusted to 1000 rpm and the reaction temperature was maintained at 60°C. The 
minimum pH was adjusted to 10 by adding concentrated NH4OH using an injectable 
syringe. The resultant precipitate was aged for 24 h under stirring at the same speed. After 
aging, the obtained white precipitate was filtered, washed four to five times with distilled 
water until complete removal of ammonium chloride. Final precipitate was centrifuged at 
10,000 rpm for 10min and dried in oven for 24 hours at 120°C. The nHAp powder was 
finally pounded in a mortar several times in order to obtain a homogeneous powder. 
 
3.11. Preparation of Alginate and HAp composites (Alg/HAp 
Scaffolds) 
 
Alg/HAp composite scaffolds were prepared by mixing alginate 2% (w/v) and HAp 
at different concentrations in water using calcium release method. HAp powder was 
homogenously dispersed into a stirred solution of alginate in water, followed by the 
addition of GDL 60mM to release calcium ions from HAp. Aliquots of this gelling solution 
were then cured in 24-well tissue culture plates (h=18 mm, Ø=16 mm, Costar, Cambridge, 
MA) for 24 h at room temperature to allow complete gelification. The hydrogels in the 
tissue-culture plate were then step-wise cooled by immersion in a liquid cryostat. Ethylene 
Glycol in water (3:1) was used as refrigerant fluid. Temperature was decreased step-wise 
from 20°C to -20°C by 5°C steps with 30 min intervals for equilibration; the samples were 
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then freeze-dried for 24 hours to obtain porous scaffolds. For control experiments, pure 
alginate gels (HAp-free) were prepared by replacing HAp with CaCO3 (corresponding to 
30mM of Ca2+); pure alginate gels were then processed as HAp composite gels. This 
procedure was applied for both the HAp formulations: nHAp and HApF. 
 
3.12. Characterization of Hydroxyapatite particles 
 
TEM images were used to identify the average dimensions of the synthesised nHAp 
particles. Image analysis, after grey-levels segmentation, has been performed by means of 
Image Pro Plus 6.2 software on the TEM micrographs. 64 TEM images were processed 
leading to the result of an average dimension of the particles of 150 nm. 
 
3.13. Raman spectroscopy and microscopy 
 
Raman spectra of Alg/HAp hydrogels were recorded with a Renishaw “inVia” 
Raman system at 514.5 nm laser excitation coupled to a Leica DMLM microscope using a 
20X objective. A thermoelectrically cooled charge coupled device (CCD) camera was used 
for detection.  
 
3.14. XRD analysis 
 
Samples of both alginate and Alg/HAp hydrogels were studied by means of X-Ray 
diffraction technique (XRD) using a diffractometer (STOE D500, Siemens, Munich, 
Germany) with Cu Kα radiation (λ = 0.1541 nm), mono-chromatized by a secondary flat 
graphite crystal. The scanning angle ranges from 10° to 60° of 2θ, the steps were of 0.02 of 
2θ and the counting time was of 2s/step. The current used was 20 mA and the voltage 40 
kV. 
 
3.15. X-ray micro-computed tomography (µ-CT) 
 
X-ray micro-computed tomography of samples was obtained by means of a cone-
beam system called TOMOLAB (www.elettra.trieste.it/Labs/TOMOLAB)(Mancini et al., 
2007). The device is equipped with a sealed micro-focus X-ray tube, which guaranteed a 
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focal spot size of 5 microns, in an energy range from 40 kV up to 130kV, and maximum 
current of 300µA. As a detector was used a CCD digital camera with (49.9×33.2) mm2 
field of view and a pixel size of (12.5×12.5) µm2.  
The samples were positioned onto the turn-table of the instrument and acquisitions 
were performed with the following parameters: distance source-sample (FOD): 100mm; 
distance source-detector (FDD): 400mm; magnification: 4x; binning: 2x2; resolution: 
6.25µm; tomographies dimensions (pixels): 1984x1024; slices dimensions (pixels): 
1984x1984; number of tomographies: 1440; number of slices: 864; E=40 kV I=200 µA; 
exposure time: from 2 to 5 seconds. The slices reconstruction process achieved by means 
of commercial software (Cobra Exxim) started once the tomographic scan was completed 
and all the projections were transferred to the workstation. Input projections and output 
slices are represented by files (one file per projection and one file per slice) using arrays of 
16-bit integers. Custom produced MatLab code has been used to get a proper segmentation 
of the slices using Otsu’s(Otsu, 1979) method and to obtain numerical values of structural 
features like porosity, interconnection, pore and trabecular size by means of parallel plate 
model (Parfitt et al., 1983). 
 
3.16. Scanning electron microscopy (SEM) 
 
Scaffolds structure was analyzed using a Leica-Stereoscan 430i Scanning Electron 
microscope. Freeze-casted samples were sectioned at various planes and directly visualized 
by electron microscopy after sputter-coating with an ultrathin layer of gold. Scaffolds 
seeded with cells were rinsed with 10 mM HEPES pH=7.4 containing 10 mM CaCl2, 100 
mM NaCl, 5 mM glucose and fixed with 10% glutaraldehyde in PBS for 1h at room 
temperature. Samples were then washed three times with water, dehydrated by step-wise 
treatment with ethanol and finally dried with a critical point dryer, sputter-coated with gold 
and visualized by electron microscopy. 
 
3.17. Preparation of Simulated Body Fluid (SBF) 
 
The solution for in vitro modelling was SBF (Kokubo et al., 1990a; Kokubo et al., 
1990b) with a pH of 7.40 and ion concentrations nearly equal to those of human blood 
plasma (Na+ 142.0, K+ 5.0, Mg2+ 1.5, Ca2+ 2.5, Cl− 147.8, HCO3− 4.2, HPO42− 1.0, SO42− 
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0.5 mM). The SBF was prepared by dissolving reagent-grade chemicals of NaCl, NaHCO3, 
KCl, K2HPO4 ·3H2O, MgCl2·6H2O, CaCl2 distilled water and buffering at a pH of 7.40 
with tris(hydroxymethyl)aminomethane (CH2OH)3CNH2 and 1.0 M hydrochloric acid  at 
36.5 ◦ C. 
 
3.18. Swelling and dissolution behaviour 
 
The swelling behaviour of the scaffolds was investigated by exposure to mQ water 
and to Simulated Body Fluid (SBF). The specimens were cylindrical in shape with an 
average diameter of 16 mm and a thickness of 4 mm. The swelling behaviour was 
quantified by measuring the changes in sample weight as a function of sample immersion 
time in water and SBF. Wet weighs were determined after blotting with a filter paper to 
remove the surface water and the swelling ratio was calculated using the equation: 
 
( ) 100% ×⎟⎟⎠
⎞
⎜⎜⎝
⎛ −=
d
ds
sr W
WWE  
 
where Esr is the amount of absorbed water (weight percent) by the polymer matrix, 
Wd and Ws are the weights of the samples in the dry and the swollen state, respectively. 
The results were taken as the mean values of three measurements. 
Structural stability and integrity in water was evaluated for 4 weeks at 37°C in 
agitation. The samples were immersed in 8 ml of mQ water. Wet weight was measured 
after 10 min equilibration, at 7, 14, 21 and 31 days of immersion after blotting on filter 
paper, respectively. Soaking water was changed after each measurement. Weight variation 
was calculated using the formula:  
 
Weight variation (%) = [1 - (Wtn / W 10min)] X 100 
 
where Wtn and W 10min are the wet weights of the samples at the defined time and 
after 10 minutes of swelling, respectively. 
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3.19. Cell culture and seeding 
 
Osteosarcoma MG-63 (ATCC® Number: CRL-1427™) human cell line was 
cultured in DMEM supplemented with 10% FBS, 1% Penicillin-streptomycin/1% L-
glutamine at 37°C and 5% pCO2. Saos-2 (ATCC® Number: HTB-85™) human 
osteosarcoma cell line was maintained in McCoy's Medium with 15% FBS, 1% Penicillin-
streptomycin/1% L-glutamine at 37°C and 5% pCO2.  
For cell seeding onto scaffolds, porous freeze-casted scaffolds produced under sterile 
conditions, were reswollen in 5 mM CaCl2 for 30 min under agitation and immersed in 
complete cell culture medium for 24 hours in 24-wells culture plates to ensure chemical 
equilibration. Osteosarcoma cells, suspended in 50 µL of medium, were loaded with a 
micropipette over the whole upper surface of the scaffold. After 4 hours, the scaffolds were 
placed into fresh, sterile 24-well culture plates and 1 mL of complete medium was added. 
 
3.20. Confocal laser scanning microscopy (CLSM) 
 
Fluorescence labelled scaffolds were obtained by coupling alginate with rhodamine 
123 (Donati et al., 2007) for visualization in the CLSM. Individual constructs were placed 
on a coverslip and mounted on the stage of an inverted microscope LEICA TCS SP2 
associated with a confocal argon-ion laser scanning microscope. Confocal data have been 
processed by means of Image Pro Plus 6.2 software extended with the 3D Constructor 
package. Laser excitation light was provided at a wave-length of 488 nm, and fluorescent 
emissions were collected at wavelengths between 510 nm and 580 nm. For image 
acquisition, an exposure time of 0.8 s was adopted with a binning of 2x2 on the charge-
coupled device camera, yielding a pixel size of 1.46 µm.  
 
3.21. Cell Proliferation and viability on Alg/HAp composites 
 
The viability and growth rate of MG63 and Saos-2 osteosarcoma human cell lines on 
Alg/HAp composites were assessed as a function of time using the MTS assay according to 
the protocol provided by the manufacturer (CellTiter Aqueous One Solution cell 
proliferation Assay kit from Promega). A cell suspension of 40×103 was seeded on 
sterilized scaffolds, incubated at 37 °C in a humidified air atmosphere of containing 5% 
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CO2 and MTS assays performed in quadruplicate 1, 7, 14 and 21 days from cell seeding. 
Briefly, after 4 hours of incubation with the MTS reagent in a humidified 5% CO2 
atmosphere, the medium was collected from the scaffolds and absorbance was measured 
on an ELISA plate reader at a wavelength of 490 nm. The background absorbance obtained 
from an empty scaffold (blank) was subtracted from the sample values.  
 
3.22. Phosphatase alkaline activity (ALP) 
 
A 100×103 suspension of respectively MG63 and Saos-2 cells was seeded on the 
scaffolds and maintained in culture in complete medium at 37°C in a 5% pCO2 
atmosphere. At different days, scaffolds were washed at RT for 30 min in a buffer 10 mM 
HEPES pH 7.4 containing 10 mM CaCl2, 100 mM NaCl, 5 mM glucose and finally 
dissolved in a sodium citrate solution (50 mM sodium citrate, 100 mM NaCl, 10 mM 
glucose, pH=7.4). 
Cells were collected by centrifugation at 400×g and lysed in a TritonX-100 solution 
(0.2% w/w TritonX-100 in 100 mM Tris/HCl buffer, pH=9.8). Enzymatic activity was 
measured in a solution of 6 mM para-Nitro-Phenyl-Phosphate and 1 mM MgCl2 in Tris-
HCl 100 mM pH=9.8 after 60 min of incubation at 37°C. Absorbance was measured at 410 
nm. The results were normalized for the amount of protein content in the cellular extract 
calculated by means of BCA method according to the manufacturer’s protocol (Sigma). All 
tests were performed in quadruplicate.  
 
3.23. Preparation of the Bis-GMA/TEGDMA thermosets (F1 
preparation) 
 
BisGMA (70% w/w) and TEGDMA (30% w/w) were mixed under vigorous stirring 
at 37 °C. CQ (0.7% w/w) and DMAEMA (0.7% w/w) were added and the solution was 
protected from light and degassed for 12 hours in vacuum oven at 40 °C. The solution was 
poured in Teflon mould (∅ =14 mm, h = 2.5 mm) and the wells were covered with a PET 
film. The polymerization was light initiated with a hand cure light device (Optilux 501, λ: 
400-505 nm, light power: 850 mW/cm2) for 20 seconds. The post-curing was performed 
with a Photopol IR/UV Plus oven (Dentalfarm, Italy) equipped with 8 lamps and 2 spots 
operating in the wavelength range 320-550 nm following the procedure: 20 minutes in 
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light oven (8 lamps), 20 minutes in light oven (8 lamps) on a rotating plate, 60 minutes in 
light oven (8 lamps) under vacuum, 7 minutes in light oven (8 lamps plus 2 spots). The 
thermosets were then sandpaper polished (granulometry: 1200). 
 
3.24. Preparation of the Bis-GMA/TEGDMA thermosets (F3 
preparation) 
 
F3 is a thermal cured formulation composed of the same monomers ratio than 
formulation F1. In formulation 3, the polymerization was initiated by the thermal 
decomposition of Benzoyl Peroxide (BPO). BPO (1% w/w) was first dissolved by 
magnetic stirring in TEGDMA monomer (30% w/w) for 15 minutes at room temperature. 
Then, Bis-GMA (70% w/w) monomer was added and the mixing of the components was 
performed by manual stirring until complete homogenization. Vit E (0.3% w/w) was 
finally added to the previous batch just before the processing step. The polymerization was 
thermally initiated by exposing the resin for 1h at 100°C under vacuum. In order to 
optimize the conversion degree, two successive post-treatments under vacuum (2h at 
120°C followed by 2h at 150°C) were performed. 
 
3.25. Preparation of fibre reinforced composites (FRC) 
 
BisGMA-TEGDMA (70/30) resin was prepared as indicated in the F1 formulation. 
Strips of 10 cm length and 5cm width have been cut from the veil of E-Glass Fibre: 
Ahlstrom E-glass fibre veil (100 g/m2); lot number GFT-56G8-100. The strips have been 
impregnated with the F1 resin and aged for 24 hours. The excess of resin was then scraped 
off with a poly(methyl methacrylate) plate in order to obtain a rough and porous surface. 
All the samples were cured by dentist’s hand-cure light device (Optilux 501, λ: 400-505 
nm, light power: 850 mW/cm2). The plates were (doubly) post-cured in vacuum light-oven 
(ESPE Visio Beta vario, λ: 400-500 nm) for 15 minutes, followed by treatment in light-
oven (Ivoclar TargisPower, λ: 400-580 nm) for 30 min at room temperature.  
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3.26. Preparation of Scaffold-FRC System: Physical Interlocking 
 
Cured FRC have been vertically placed in hand-made moulds. Alg 2% gelling 
solutions were poured into the moulds and aged for 24 hours. The system were then cooled 
step-wise from room temperature to 20°C by 5°C steps with 30min intervals for 
equilibration and then freeze-dried to obtain porous scaffolds. 
 
3.27. Preparation of Scaffold-FRC System: Molecular Interlocking 
 
30mg of HAp were laid on the bottom of each well (Ø=14mm, h=2mm) of a 
polytetrafluoroethylene (PTFE) 24-multiwell. A PTFE cylinder (Ø=14mm, h=50mm) was 
used to handily press the powder. The thermoset resin (F1 or F3) (≅2mL) was poured in 
each wall. To obtain complete polymerization of the resin the proper curing treatment was 
followed (see 3.23 Preparation of the Bis-GMA/TEGDMA thermosets (F1 preparation) 
and 3.24 Preparation of the Bis-GMA/TEGDMA thermosets (F3 preparation)). 
 
3.28. Mechanical testing 
 
Compression Tests 
 
Scaffold samples were cut in regular cylinders (h=10mm, Ø=16 mm). Compression 
tests have been performed according to ASTM D 3574-95 standard by means of a Lloyd 
LRX testing equipment. The device was coupled with a 100 N load cell. The compression 
speed was set on 1 mm/min and no preload was applied. Samples have been compressed 
until the 50% of strain. The same methodology has been applied to the reswollen scaffolds 
and to the hydrogels. 10 replicates were averaged for each sample. 
 
Adhesion Tests  
 
Two separate outer layers of FRC were embedded within the Alg2% solution, 
leaving a gap of about 3mm and than freeze-dried with the same methodology of 
preparation of the scaffolds to produce a “sandwich-like” structure. Steel cylinders 
(Ø=30mm, h=45mm) have been used to anchor the FRC. The cylinders were fasten to the 
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FRC outer surface using a 3M brand number 810 bilayered adhesive tape. The samples 
were than tested by means of a Lloyd LRX testing equipment in the uniaxial tension mode. 
The device was coupled with a 100N load cell. Tensional speed was set on 1 mm/min and 
no preload was applied. Samples were extended until the point of rupture. The procedure 
was performed following the indications reported in the standard ASTM D 2651-79 
(Leung et al., 1998). 10 replicates were averaged for each sample. 
 
Shear-Stress Tests 
 
Two outer layers of FRC have been embedded with the alginate solution and then 
freeze-dried with the same methodology of preparation of the scaffolds. 3M brand number 
810 bilayered adhesive tape was used to fasten the samples obtained to polymethyl 
methacrylate plates. Tensional speed was set on 1mm/min and no preload was applied. 
Samples have been extended until the point of rupture. The procedure was performed 
following the indications reported in the standard ASTM D 2651-79. 10 replicates were 
averaged for each sample. 
 
3.29. In vivo tests 
 
The animal trial was conducted at the University of Trieste. The animals were three 
skeletally mature female New Zealand White rabbits (average weight of 3.5–4.5 kg, 
Conelli snc, Arona NO, Italy). Care of the animals followed the ‘‘European convention for 
the protection of vertebrate animals used for experimental and other scientific purposes’’ 
(1999/575/EC) and the Italian regulation (D.L. 116, 1993). The animals were anaesthetized 
and two cortical holes of 3.75 mm diameter and 8 mm depth in each femur were drilled 
under continuous saline irrigation. Alg/HAp implants and the positive control material 
(Moimas et al., 2006) were gently packed in the surgically created defect. The Alg/HAp 
implants, positive and negative controls were randomly positioned in the femur of the 
animals. After implantation, the subcutaneous tissue and skin were closed in layers with 
resorbable sutures. The animals received a postoperative pain medication and were allowed 
to move without any restrictions immediately after recovery from the anaesthesia. The 
duration of the trial was 6 weeks. After this time the rabbits were euthanized and the femur 
dissected and prepared for the analysis. The single and long implantation time was chosen 
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because no information was found in the literature on the resorption time of such implants 
and also there were a limited number of animals available for the study. 
 
3.30. X-ray micro-computed tomography of ex vivo samples 
 
Samples were dissected from the femurs and immediately reduced and fixed for four 
days at 4°C in buffered 5% solution of formaldehyde (Carlo Erba, Rodaro, Milan). After 
removal of fix solution excess with o/n washing in running water, the specimens were 
subjected to dehydration in a graded series of ethanol (30%, 50%, 70%, 90%, 100%) for 
one hour each bath. After complete dehydration the sample were dried overnight at room 
temperature under calm air. Basically the µ-CT scans of the ex vivo samples followed the 
description reported in 3.15 X-ray micro-computed tomography (µ-CT).  
 
3.31. Light Microscopy and Histological Analyses 
 
Samples were dissected from the implanted femur dyaphises, immediately reduced at 
level of the implants and fixed in buffered 5% solution of formaldehyde (Carlo Erba, 
Rodaro, Milan) for four days at 4°C. After fixation agent removal and washing in running 
water, the specimens were decalcified with EDTA 19% in aqueous solution, pH 7.4 
(Fluka/Sigma-Aldrich, GmbH, Milan) and then dehydrated in graded ethanols (Carlo Erba, 
Rodaro, Milan), cleared with xylene (J.T. Backer, Deventer, Holland) and embedded in 
paraffin (Sherwood Medical Co., St Louis, MO, USA). Sample cutting was performed with 
a 2050 Supercut microtome (Reichert-Jung, Cambridge Instruments Inc, New York) and 
sections were mounted onto albumin-coated slides (Carlo Erba, Rodaro, Milan). 
Histological sections were subjected to (i) conventional staining with Hematoxylin and 
Eosin, (ii) histochemical reaction for polyanion localization using 0.05% Alcian Blue 8GX 
dissolved in 0.25M acetate buffer containing 0.05M MgCl2, pH 5.6, at room temperature, 
for 4 hours, and (iii) as in (ii) plus counterstaining with Hematoxylin-Eosin. 
 
3.32. Fluorochrome bone labelling  
 
During the post operative course five fluorochromes were administrated to the 
rabbits in order to evaluate the mineralized matrix deposition kinetics. The different 
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fluorochromes, calcein blue, xylenol orange, calcein, alizarine red and doxycycline were 
adjusted to pH values of 7.2, sterilized by filtration and administered sequentially every 
week starting at day 4 by subcutaneous injection. Details of the fluorochromes are given in 
Table hereafter.  
 
Time Fluorochrome Dose 
1° week Calcein (λ ex.494 nm; λ em.517 nm) (15 mg/Kg) 
2° week Calcein blue (λ ex.373 nm; λ em.420 nm) (30mg/kg) 
3° week Xylenol orange (λ ex.440/570nm; λ em.610 nm) (90 mg/Kg) 
4° week Alzarine red (λ ex. 530/580 nm; λ em.624-645 nm) (30mg/kg) 
5° week Doxiciclina (λ ex.340-425 nm; λ em.580 nm) (50 mg/Kg) 
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4. RESULTS AND DISCUSSION 
 
4.1. Research Strategy 
 
Ideally, the final aim of this thesis is to produce a new generation of bone prostheses. 
In the introduction, it has been evidenced the obsolete usage of metallic prosthesis for 
orthopaedic applications. In this framework, normally, two different kinds of prosthesis are 
required: 
 
i. load bearing prosthesis; 
ii. non-load bearing prosthesis. 
 
The two implants differ both from the site where they are meant to be employed and 
from their usage. For example, a femur, which normally undergoes to high cycles of loads, 
may require a device which is able to carry the loads – it is the case when a large part of 
the bone have been extracted due to diseases – or a structure which act as a filler for sub-
critical defects, i.e. to help the healing of a fracture. Starting from this concept, a construct 
named scaffold, which was able, under several conditions, to act as a temporary support for 
the cell colonization or as an osteoconductive coating for non-metallic load bearing 
prosthesis was developed. Thinking in a reductional manner, the target was confined in 
two different areas: the scaffold and the load bearing structure, and from this point the 
investigation started to identify the components that could fit the needs. Therefore, the 
study was drawn from its final application to its singular component which was selected on 
specific requests.  
The scaffold (Figure 4 and Figure 5) was conceived as a porous structure able to 
mimic the features and the environment of the cancellous bone. Therefore, casting 
strategies and suitable components which could respond to these requests were selected. 
The features of the single components and of the final three-dimensional structure were 
extensively investigated with all the possible examination resources in order to obtain the 
most clarifying characterization as in terms of physical-chemical properties as from the 
paramount biological point of view. Once the in vitro behaviour of the structure was clear, 
in vivo tests were performed. 
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Figure 4: Three-dimensional porous structure: scaffold. 
 
Figure 5: Coronal (top left) and Transverse section (bottom left) section of the sample used to derive 
the scaffold. The right image represents the 3D visualization of the volume marked in red in the 
sections. 
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The non-metallic load bearing prosthesis was designed as a central core of composite 
material, able to carry the loads, and an outer osteoconductive layer – the scaffold – able to 
promote integration between the surrounding native bone and the core of the prosthesis 
Figure 6. Therefore, the prototype of the composite material for the load bearing core was 
selected based on its mechanical features in order to avoid the problem of stress-shielding 
which could result in resorption of the surrounding bone (as reported in the Introduction 
chapter). Then, with the knowledge achieved from the previous investigation on the 
scaffold, this latter component have been linked to the surface of the load bearing core in 
order to obtain a final construct which was able both to sustain the loads and to integrate 
with the osseous tissue. 
 
 
Figure 6: Schematic representation of the Load-Bearing composite prosthesis. 
 
In this section Results and Discussion are reported. The order in which the results 
will be presented do not reflect the chronological or methodological order in which they 
have been achieved. Instead, for a better understanding, they are described from the 
individual component of the structure to the final product of the investigation. 
 
 
                                                        Results and Discussion                                                    a 
-57- 
4.2. Individual Scaffold Components 
 
4.2.1. Structural Characterization of the (hydrated) Alginate Gel Network 
 
Texture analysis of TEM micrographs 
 
In this section morphological characteristics of a calcium alginate gel are evaluated 
and compared in order to quantify the three dimensional (3D) structure of the hydrogels 
(Brun et al., 2010). A set of textural descriptors based on histogram analysis as well as on 
Grey Level Co-occurrence Matrix (GLCM) and on fractal dimension is extracted from 
Transmission Electron Microscopy (TEM) micrographs in order to describe the 
morphological differences that the images present.  
Figure 7, Figure 8 and Figure 9 illustrate Regions Of Interest (ROIs) derived from 
TEM micrographs of calcium alginate gels after recording at three different magnification 
factors. The alginate gels exhibited an entangled texture in which linear/bent filaments 
delimited roughly polygonal voids sized according to a pseudo-hierarchy, with the axes of 
the largest ones reaching about 0.5 µm. Table 2 reports the mean values and the standard 
deviations (SD) calculated for each set of four images at each of the six magnifications for 
each considered textural descriptor (see Materials and Methods section). 
 
  Histogram  GLCM  Fractal 
  µ σ S U e  C R E H  D 
3800X Mean 129,6 57,6 0,049 0,0047 7,81  0,74 0,856 0,064 0,755  2,865 
 SD 9,2 2,2 0,003 0,0002 0,04  0,06 0,003 0,004 0,009  0,007 
10000X Mean 118,3 58,3 0,050 0,0047 7,79  0,45 0,915 0,080 0,816  2,679 
 SD 5,1 1,4 0,002 0,0001 0,02  0,02 0,002 0,002 0,005  0,005 
22000X Mean 137,9 59,3 0,051 0,0051 7,74  0,38 0,931 0,102 0,839  2,638 
 SD 14,7 3,2 0,005 0,0001 0,01  0,04 0,002 0,004 0,008  0,010 
35000X Mean 147,9 58,3 0,050 0,0053 7,70  0,34 0,937 0,106 0,847  2,668 
 SD 9,3 1,5 0,003 0,0001 0,01  0,02 0,001 0,007 0,004  0,010 
45000X Mean 148,1 57,9 0,049 0,0055 7,68  0,36 0,929 0,107 0,837  2,761 
 SD 13,7 3,7 0,006 0,0002 0,03  0,01 0,006 0,009 0,003  0,014 
60000X Mean 150,4 59,9 0,052 0,0050 7,77  0,44 0,920 0,085 0,810  2,858 
 SD 8,0 2,4 0,004 0,0001 0,01  0,01 0,007 0,004 0,004  0,010 
 
Table 2: Mean values and Standard Deviations of the ten considered textural descriptors calculated at 
the six magnification factors. 
 
The dependence of the descriptors on the magnification factor clearly points to the 
critical influence of this important parameter. In particular, some descriptors present an 
abrupt change from a magnification of 3800x to 22000x remaining almost constant from 
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22000x to 45000x while other parameters fluctuate and the histogram mean parameter rises 
on passing from 3800x to 60000x. This could basically due to the fact that the image 
resolution for the 3800x magnification factor is inadequate to analyze the specific 
structure, probably being unable to detect voids with dimensions (and shapes) below a 
critical but significant value. On the other hand, the ROI for the 45000x or 60000x 
magnification factors does not include all the heterogeneous features forming the effective 
texture of the material, thus affecting the results. On the contrary both the errors on the 
descriptors (due to the different ROIs) and the differences among magnification factors are 
much smaller. This could mainly be due to an intrinsic greater image similarity at the 
different magnifications.   
The analysis in different ROIs, derived from the TEM micrograph, seems to 
demonstrate the irrelevance of the selected area on many parameter values while the 
examination at different magnification factors shows a variable influence of this factor 
(depending on the parameter category) and indicates that GLCM-based descriptors as well 
as fractal dimension and an intermediate magnification factor (either 22000x or 35000x) 
are a good choice for this type of samples. Among the various descriptors examined in this 
study, it is reasonable to conclude that the GLCM-based descriptors (particularly GLCM 
contrast and energy) can be preferred as robust descriptors for the texture of the hydrogels. 
 
 
Figure 7: TEM micrograph (after median filtering) of the Alg 2% hydrogel. Magnification: 3800x. 
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Figure 8: TEM micrograph (after median filtering) of the Alg 2% hydrogel. Magnification: 22000x. 
 
 
Figure 9: TEM micrograph (after median filtering) of the Alg 2% hydrogel. Magnification: 60000x. 
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Mechanical Testing and Rheology 
 
The ultimate effect of polymer reticulation and water structuring is on the 
mechanical performance of Alg hydrogels. Although an enormous wealth of experimental 
and theoretical work has been accumulated over the years to understand the mechanical 
behaviour of Alg gels, still it was desired to carry out mechanical and rheological testing 
on the actual systems used here in the preparation of scaffolds.  
Young’s Modulus (E) was determined on 2% Alg gels by means of uniaxial 
compression tester. The results provided a value E = 20±13 kPa, in very good agreement 
with previously reported values (Donati and Paoletti, 2009; Donati et al., 2005; Pasut et al., 
2008; Rayment et al., 2009; Wang et al., 2005). 
Rheological experiments were carried out in Frequency Sweep oscillating mode (see 
Materials and Methods section) for Alg concentrations (Cp) of 1%, 2% and 4%. The 
results, deconvoluted into the viscous (G”) and the elastic (G’) components, are reported in 
Figure 10. In all cases both G’ and G” were practically constant over a large range of 
frequency, being G’ always predominant than G”, as expected for a strong gel (Cappelli et 
al., 2009; Grassi et al., 2009). Frequency sweep tests were interpreted by means of the 
generalized Maxwell model representing material rheological behaviour by means of a 
sequence of Maxwell elements in parallel, each one constituted by a spring and a dashpot 
in series. This model states that elastic and viscous character of the material are 
represented by the elastic (G’) and viscous (G”) moduli that depend on pulsation ω 
according to the following equations (Grassi et al., 2009): 
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where n is the number of Maxwell elements considered, Gi, ηi and λi represent, 
respectively, the spring constant, the dashpot viscosity and the relaxation time of the ith 
Maxwell element, while G∞ is the spring constant of the last Maxwell element which is 
supposed to be a pure elastic element without its dashpot (G∞ is typical of purely elastic 
network, i.e. of a chemically cross-linked network). The results have been analyzed using 
in all cases one elastic component, and four Maxwell elements for the 1% and 2% cases, 
and five Maxwell elements for the 4% case, respectively (Pasut et al., 2008). 
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Figure 10: Hydrogel mechanical spectrum. Comparison between experimental elastic (G′) and viscous 
(G′′) moduli with Maxwell’s element model best fitting (lines). ω is the pulsation ( 2πf, f solicitation 
frequency). 
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Assuming that hydrogel shear modulus G is the sum of the elastic contributes (Gi) of 
each Maxwell element, the values of G for the three systems are reported in Figure 11. 
They show an astonishingly linear behaviour through the origin, corresponding to a power-
law of the type: 
 
Equation 1 
 
G ∝ (Cp)β 
 
with β = 0.985±0.019 (R2 = 0.9996) (Figure 11, inset), and, apparently, no lower 
value of Cp has the onset on the elastic behaviour. This finding is in excellent agreement 
with that of H.-J. Kong et al. (Kong et al., 2002) for a 1:1 mixture of two alginate samples 
of different molecular weight (MW), namely 269.1 kDa and 53.1 kDa, respectively. The 
MW of the presently used sample is 130 kDa.  
 
 
Figure 11: Shear Elastic Modulus (G) calculated as the sum of the elastic contributes (Gi) of each 
Maxwell’s element. Points represent the experimental data; dot dashed line is the linear fitting. 
 
The determination of the shear modulus through rheological characterization allows 
an estimation of the polymeric network nanostructure via the determination of the cross-
link density ρx, defined as the moles of junctions between different polymeric chains per 
hydrogel unit volume. Flory’s theory (Flory, 1953) ensures the following relations between 
ρx and hydrogel shear modulus  
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Equation 2 
 
ρx =G/RT 
 
where R is the universal gas constant, T is the temperature, and G has be computed 
as the sum of the elastic contribution (Gi) pertaining to each element of the generalized 
Maxwell’s model describing hydrogel mechanical spectrum, as anticipated (Pasut et al., 
2008; Grassi et al., 2009). Equation 2 holds for the case where network cross-linking is 
performed in wet conditions, namely when polymeric chains undergo cross-linking in 
solution without undergoing further swelling (i.e. the situation of the present work). The ρx 
values calculated from the G data are reported in Figure 12, of course showing the same 
linear dependence on Cp as G, from which they have been derived. Nevertheless, the 
values are remarkably similar to those of H.-J. Kong et al. (Kong et al., 2002) for 
comparable average MW. 
 
 
Figure 12: Cross-link density ρx as a function of the polymer concentration. Points represent the 
experimental data; dot dashed line is the linear fitting. 
 
The knowledge of ρx, jointly with the equivalent network theory (Schurz, 1991), 
allows the estimation of the polymeric network average mesh size, ξ. In spite of the 
crudeness of the approximation, still the value of ξ can provide a reasonable estimate of the 
distance between cross-links in the ideal system, elastically equivalent to the actual gel 
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under investigation. Assuming a spherical symmetry for the space allotted to each mesh 
element (therefore, of radius ξ), one can estimate ξ from ρx as: 
 
Equation 3 
 
3
6
Ax Nπρξ =  
 
where NA is Avogadro’s number. 
In the present case, the estimated values of ξ are 5.1 nm, 4.1 nm and 3.3 nm for the 
gels at 1%, 2% and 4%, respectively. Those values clearly appear as too small to be even 
remotely associated with the real distance between the alginate gel junctions, namely the 
“egg-box” structures. Clearly, to get a realistic picture one should take into account that in 
the real systems a considerable fraction of the polymer repeating units is involved in such 
junctions, thereby increasing the distance (reducing the mesh size) of inter-junction 
stretches. A range of pore sizes from 2 to 200 nm have been reported in the pioneering 
studies by Andresen et al. (Andresen et al., 1977), which places the present estimated 
values on their lower side. Further experimental and theoretical work is certainly needed 
before a safer correlation can be achieved. Nevertheless, the approach seems to catch the 
“order of magnitude” of the 3D arrangement of the elastic Alg gels. 
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Nuclear Magnetic Resonance 
 
Structural properties of Alg gels, and consequently of the Alg based scaffolds, are 
strongly correlated to the physical and chemical properties of the polysaccharide. Low 
field Nuclear Magnetic Resonance (NMR) relaxometry can give valuable information 
about the Alg hydrogel phase. The behaviour of the Alg solutions, prepared as reported in 
the Materials and Methods section, was investigated as a function of the polymer 
concentration in order to understand the final hydrogel condition. Five different 
concentrations were selected: 0.5%, 1%, 2%, 3% and 4%. The behaviour of the solvent 
(aqueous HEPES 10mM; NaCl 150mM; pH=7.4), Alg 0%, was observed as well. These 
analyses were essential to understand the relaxation times of the polymer in its simplest 
phase: the solution one.  
Transverse relaxation times of Alg solutions have been obtained by fitting the 
experimental data (Figure 13) with the Levenberg-Marquardt algorithm (Press et al., 1992) 
to the mono-exponential decay of the type: 
 
Equation 4 
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1
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Figure 13: Experimental data for relaxation time of Alg 2% solution. 
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For this set of analyses the experimental data for the relaxation time T2 (Figure 13) of 
each polysaccharide concentration were perfectly fitted by a Levenberg-Marquardt 
algorithm with a single exponential (Equation 4). 
The effect of polymer concentration, Cp, on T2 was analysed by varying Cp from 
0.5% to 4%. In each case the decay curve could be fitted by a single exponential, thereby 
producing T21 values for each Cp. The results have been reported in Figure 14, as crosses. 
In particular, from Figure 14 it can be noted that the relaxation time decreases as the 
polymer concentration increases. This behaviour can be explained if one takes into account 
the viscosity of the polymer solution, which increases with the polymer concentration, 
thereby progressively hindering the relaxation of the solvent water. 
 
Figure 14: Transverse relaxation times of Alg solutions (×), and long relaxation times (T21) for 
hydrogels (), as a function of polysaccharide concentration. 
 
The hydrogel system, hereby investigated as Alg beads (see Materials and Methods 
section), was more complicated to describe. It is well known from literature that the NMR 
analysis of these systems reveal a multi-modal distribution of the components of the 
transverse relaxation time. This behaviour could be described by the exponential elements 
of Equation 5 which correspond to different conditions for the hydrogen atoms belonging 
to the water contained in the hydrogel (Cappelli et al., 2009; Booth and Packer, 1987; 
Brownstein and Tarr, 1979).  
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Equation 5 
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This is a multi-exponential function where t is the time, Ak is the (normalized) pre-
exponential factor for the k element and T2k is the relaxation time for the k element 
( 1
1
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k
kA ).  
The system of Alg beads analysed as a function of the concentration of 
polysaccharide could be described by two exponentials. The values of the two T2k 
components, as well as the corresponding (normalized) peak areas, are reported in Table 3.  
 
Beads Alginate 4%   Alginate Solution 4% 
Ai(%) T2i(ms)  T2i(ms) Ai(%) 
3.6 ± 0.2 461.6 ± 20.0 T21 382.6 ± 0.2 100 ± 0.1 
96.4 ± 0.3 57.3 ± 0.3 T22   
Beads Alginate 3%   Alginate Solution 3% 
Ai(%) T2i(ms)  T2i(ms) Ai(%) 
5.2 ± 0.1 584.8 ± 10.2 T21 489.1 ± 0.2 100 ± 0.1 
94.8 ± 0.3 72.9 ± 0.3 T22   
Beads Alginate 2%   Alginate Solution 2% 
Ai(%) T2i(ms)  T2i(ms) Ai(%) 
8.5 ± 0.1 668.4 ± 5.8 T21 667.5 ± 0.2 100 ± 0.1 
91.5 ± 0.4 97.6 ± 0.5 T22   
Beads Alginate 1%   Alginate Solution 1% 
Ai(%) T2i(ms)   T2i(ms) Ai(%) 
12.3 ± 0.2 1124.9 ± 4.9 T21 1018.5 ± 0.3 100 ± 0.1 
87.7 ± 0.3 126.5 ± 0.6 T22   
Beads Alginate 0.5%   Alginate Solution 0.5% 
Ai(%) T2i(ms)   T2i(ms) Ai(%) 
16.3 ± 0.1 1163.9 ± 4.4 T21 1405.0 ± 0.3 100 ± 0.1 
83.7 ± 0.4 135.6 ± 0.2 T22   
Gelling Solution   Alg Solvent 
Ai(%) T2i(ms)   T2i(ms) Ai(%) 
100.0 ± 0.1 2056.3 ± 0.3 T21 2128.2 ± 0.3 100.0 ± 0.2 
 
Table 3: Modes of the transverse relaxation times T2k of Alg hydrogels and solutions. 
 
 
To understand this behaviour we firstly correlated the transverse relaxation times of 
the beads with the ones of the corresponding concentration of polysaccharide in solution. 
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In Figure 14 the values of the long relaxation time (T21), for both hydrogels and solutions, 
have been reported as a function of the concentration. As it can be clearly seen, there is a 
good correlation between the relaxation times of the two physical states of Alg. This 
allows concluding that in the hydrogel structure there is still the presence of water protons 
that behave very closely to those present in conditions where Alg is not cross-linked. With 
this in mind it has been hypothesized that this Alg could belong either to a semi-
microscopically heterogeneous structure of the beads, possibly arising from the 
manufacturing process, or to a more complicated microstructure of Alg.  
The former hypothesis seems to be unlikely according to the previous analyses of the 
Alg beads prepared with the same method followed here (Strand et al., 2004; Strand et al., 
2003). In these works the authors claimed that the beads were completely homogeneous 
and therefore there was no shell-like membrane on the Alg beads with an internal non-
gelled solution.  
The latter hypothesis led to the model described hereafter. The microstructure of Alg 
hydrogel beads can be conceived as a rather homogeneous mixture of more rigid inter-
polymeric associations, around which the protons of the hydration water rapidly relax. 
They may be reasonably associated with the “egg-box” junction zones of the gel. Such 
highly cross-linked polymer network is likely interpenetrated by a 3D “micro-capillary” 
system where the volume fraction of polymer is much lower than in the junction network 
(where polymer chains can be regarded as dangling, or, anyway, very free to move), the 
diffusion of low to medium molecular weight solutes is comparatively high and the water 
protons altogether perceive a relaxation environment very similar to that experienced in 
polymer solutions. It is not possible to exclude that part of this more mobile environment 
becomes progressively predominant upon moving toward the bead surface. The 
dependence on the polymer concentration of the two relaxation components and their 
corresponding (normalized) areas are reported in Figure 15. The trend of T21 vs. Cp, as 
already anticipated in the discussion of Figure 14, points to a marked decrease of values 
upon increasing Cp. More interestingly, it can be noticed that the corresponding areas 
constitute a minor component (in the order of 10% or less) of the total T21-relaxing 
protons, and that, moreover, it decreases parallel to the decrease of T21. Also the rapidly 
relaxing component associated with T22 decreases with the increase of polymer 
concentration in the bead: that is exactly expected for gels of increasing rigidity. In 
parallel, the relative weight of such component (A22) of the proton population increases up 
to more than 95%. 
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Figure 15: Polymer concentration dependence of the relaxation time components (panels on the left) 
and of the corresponding areas (panels on the right) of the longer relaxation component, T21, (upper 
row) and of the shorter relaxation component, T22, (lower row). 
 
 
The previously reported Figure 11 shows that the shear modulus grows linearly with 
Cp; the present finding of Figure 15 suggests that the strengthening of the gel structure is 
accompanied by a less-than-linear increase of the amount of water molecules to a different 
extent associated with the gel junctions and, oppositely, by a very fast decrease of their 
mobility. 
 
Concluding, this set of combined investigations: Image Analysis, Rheology and 
Nuclear Magnetic Resonance allowed a better understanding of the microscopic structure 
of the Alg hydrogels leading to a wide overview of the “starting system” from which the 
scaffolds will be produced. 
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4.2.2. The inorganic component: Hydroxyapatite 
Characterization and comparison of commercial HApF and nHAp 
 
In this work two different hydroxyapatite formulations have been employed. One 
was a commercial hydroxyapatite powder (HApF) from Fluka (USA), the other was a 
home made nano-hydroxyapatite (nHAp) prepared by wet chemical method (Murugan and 
Ramakrishna, 2004). In order to characterize the physical-chemical properties of the nHAp 
several analyses were carried out. First of all, the prefix nano to the compound were 
assigned after a TEM investigation. TEM images were used to identify the average 
dimensions of the synthesised nHAp particles. Image analysis, after grey-levels 
segmentation, has been performed by means of Image Pro Plus 6.2 software on the TEM 
micrographs. 64 TEM images were processed leading to the result of an average dimension 
of the particles of 120 nm (Figure 16).  
 
TEM micrograph of nHAp particles nHAp particle size distribution 
Figure 16: Image analysis on TEM micrographs of nHAp. 
 
Chemical characterization of the nHAp powder was achieved by means of Raman 
spectroscopy. Figure 17 reports the Raman spectra of both nHAp and HApF compared 
with a literature reference (Jillavenkatesa and Condrate SR, 1998). Analysis displayed a 
perfect overlapping of the main characteristic peaks of the two individual compounds and 
those reported in literature. In particular, we observed the following peaks: 
•  432 and 442 cm-1 correspond to the factor group splitting of the ν2 bending 
vibrations of the PO43- ion; 
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• 579, 592 and 608 cm-1 belong to the ν4 fundamental vibrational mode and 
arise from the triply degenerate bending vibrations of the PO43- ion; 
• the intense band at 962 cm-1 arises from the symmetric stretching modes 
and is designated as the ν1 fundamental vibrational mode of the PO43- ion; 
• 1025, 1047, 1075 and 1087 cm-1 arise from the ν4 fundamental vibrational 
modes and are due to the asymmetric stretching vibrations of the P-O bonds. 
 
Moreover, the XRD pattern of the two HAp powders (Figure 18) contains all the 
main characteristic peaks present in the JCPDS reference file for HAp (Sudarsanan and 
Young, 1969). Cytotocompatibility investigation was conducted on the nHAp powder  
with two different osteoblast-like cells leading to the conclusion that there were no 
cytotoxic effects (data not reported). These analyses, allowed considering the nHAp 
powder as a valuable alternative to the commercial HApF.  
 
All the following investigations have been assessed on the nHAp that, from now on, 
will be named simply as HAp.  
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Figure 17: Raman Spectra of A): nHAp and commercial HApF; B): Literature reference 
(Jillavenkatesa and Condrate SR, 1998). 
 
 
Figure 18: XRD pattern of nHAp and HApF powders. 
 
 
                                                        Results and Discussion                                                    a 
-73- 
4.3. Biocomposite Structure Tailoring for non-load bearing 
Applications 
 
4.3.1. Casting and Characterization of the Dry Scaffold 
 
The main target of this work was to produce of an isotropically very homogeneous 
type of porous scaffold based on Alg and HAp. The strategy devised to achieve this goal 
was based on the combination of two physical chemical processes, sequentially applied in 
different steps. In the first one a homogeneous calcium-alginate gel is produced in water; 
in the latter one the solvent is removed allowing the formation of pores as a result of 
solvent/solute phase separation.  
Alginate is known to produce strong and stable gels with calcium; however, the 
polymer/ion affinity is so high that special precautions must be taken to avoid formation of 
randomly distributed zones of inhomogeneity. A homogeneous gel can be prepared only if 
calcium ions can be uniformly released in a controlled way throughout the polysaccharide 
solution, instead of being directly added as external cross-linking agents (i.e. CaCl2, 
CaCO3). Lin et al. reported the preparation and characterization of an Alg/HAp scaffold by 
blend mixing of the polysaccharide and CaCl2 solution with the homogeneity granted by 
the use of a homogenizer (Lin and Yeh, 2004). However the main limitations of those 
constructs were a very low structural and morphological stability associated with the 
inability of the different scaffolds formulations to sustain cell viability and growth. In this 
work the hydrogels were prepared by means of a release of calcium ions by the inorganic 
component due to a slight environment acidification with GDL. Various calcium salts can 
be used as reservoirs of Ca2+ ions for acid displacement (Draget et al., 1990): we resorted 
to use HAp for this purpose owing to its fundamental role of inorganic component of bone 
and its ability to interact with living tissues. The advantage of this “internal” gelation 
process resides in the slow hydrolysis of GDL that provides for a delay time between the 
suspension of the lactone and the gelling of Alg, allowing homogeneous gel formation and 
casting of different gel shapes. 
The porous interconnected isotropic structure of scaffolds was then achieved through 
a process of thermally induced phase separation and subsequent sublimation of the solvent 
by freeze-casting. Different freezing conditions and concentrations of HAp have been 
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preliminary investigated, in order to obtain a good balance between the structural features 
and the polymer/mineral ratio.   
The most common procedure followed in freeze-casting involves unidirectional 
freezing conditions, which always lead to the formation of anisotropic lamellar structures. 
Using this method, we obtained long parallel pores aligned in the movement direction on 
the ice front (Figure 19), in agreement with what reported by Qi et al. (Qi et al., 2008). On 
the contrary, isotropic porous interconnected structures were obtained by a non-directional 
freezing by immersion in a cryostat. Suitable pore size (100-300 µm) was achieved by 
setting the cooling rate: a temperature decrease from 20°C to -20°C by 5°C steps with 30 
min equilibration intervals resulted to be the best in terms of structural features (Figure 20 
A and B). For lower cooling rates the final microstructure was characterized by larger 
pores (> 500 µm) and, conversely, for faster cooling rate smaller pores were obtained 
(<100 µm) (data not shown). The constructs displayed a homogeneous and uniform 
distribution of the HAp throughout the entire structure from the exterior to the internal part 
of the scaffold. The HAp granules seem to be entrapped in the polymer matrix resulting in 
a very rough surface of the pore walls (Figure 20 D). At the highest magnification, the 
grain of the original inorganic component appears as a modulating factor of the roughness 
of the granules (Figure 20 D). 
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Figure 19: SEM micrographs of Alg/HAp scaffold freeze-casted by directional freezing. Parallel 
lamellas are oriented along the direction of the ice front. A) and B): magnification 100X. 
 
  
  
 
Figure 20:  
A): 20x SEM micrograph showing the uniform pore size distribution; inset: 3D appearance of the 
Alg/HAp scaffold; B): 100x SEM micrograph of the interconnectivity feature of the scaffold;  
C): 1000x SEM micrograph of the HAp granules uniformly dispersed on the polymer matrix;  
D): 3000x SEM micrograph of the HAp granules showing the coarseness of the inorganic component. 
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Physical-Chemical Characterization 
 
To assess the chemical stability of Alg and in particular of HAp after the gelification 
process, the scaffolds prepared with Alg and HAp have been analysed from a chemical and 
crystallographic point of view by means of Raman spectroscopy and XRD, respectively. 
Direct comparison of the Raman peaks (assigned according to literature data 
(Jillavenkatesa and Condrate SR, 1998; Kontoyannis et al., 1997; Heinemann et al., 2005; 
Krafft and Sergo, 2006)) of the powder forms of both HAp and Alg with the corresponding 
ones obtained from the analysis of the composite hydrogels displayed a perfect overlapping 
(Figure 21 A). Moreover, the possibility of scanning extended areas of the composite 
scaffold by Raman technique allowed confirming the uniform distribution of HAp along 
the bulk of the sample. XRD analyses were performed on the freshly prepared hydrogels 
for both Alg-CaCO3 and Alg/HAp compositions. As reported in Figure 21 B, the XRD 
patterns of the Alg/HAp hydrogel sample result to be the sum of those of the bare Alg 
hydrogel and the HAp powder. 
 
  
Figure 21: A): Raman spectra of the Alg/HAp scaffold components: HAp powder (a), alginate powder 
(b), Alg/HAp freeze-casted scaffold (c).  
B): XRD pattern of the Alg/HAp scaffold components: HAp powder (a) 2%, Alg 30mM, CaCO3 
60mM, GDL freshly prepared gel (b), Alg/HAp freshly prepared gel (c). 
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Mechanical Characterization 
 
The concept prosthesis developed in this work consists of a central core of FRC with 
an external osteoconductive coating. Therefore, the FRC core is considered as the 
construct’s unit able to sustain the stresses which the prosthesis undergoes during its 
normal employment whereas the composites scaffolds are meant to be used as shape-cast 
temporary interface between the prosthesis’s core and the native bone. Since stresses 
associated with implant surgery and physiological mechanical stimuli are much lower than 
those required by load-bearing applications, the requirements in scaffold mechanical 
properties are not stringent. Nevertheless, compression moduli of about 10-20 MPa are 
considered as largely acceptable for such applications (Mathieu et al., 2006; Oliveira et al., 
2006). Moreover, if the composite scaffold is conceived as bone filler, external fixations 
are meant to be employed to sustain the load stresses (Ziran et al., 2007).  
Mechanical properties of the polysaccharide based scaffolds have been assessed by 
measuring their Young’s modulus (E) and Ultimate Compression Strength (σUCS) under 
uniaxial compression on dry and wet samples (Figure 22).  
 
 
Figure 22: A) Compression device; B) Particular of a compressed sample; 
C1) Uncompressed freeze-dried scaffold; C2) Uncompressed reswollen scaffold; 
C3) Compressed reswollen scaffold. 
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The compression stress-strain curve of the polysaccharide based composites was 
recorded and the Young’s modulus of the sample was obtained by means of a linear fitting 
of the stress-strain relationship between strain 0% and strain 0.5%. Moreover, the effect of 
the addition of HAp on the mechanical properties of the HAp-free samples – gels, freeze-
casted and reswollen – was also evaluated (Figure 23).  
Overall, an increase of the mechanical features, E and σUCS, was observed following 
the addition of the inorganic compound in comparison with the HAp-free samples. The 
compressive modulus of the Alg/HAp gels was 83.0 kPa whereas the one of the HAp-free 
gels was 20.0 kPa, corresponding to 315% increase. In the same way, the compressive 
modulus of the Alg/HAp freeze-casted samples (6.3x103 kPa) increased of 80% if 
compared with the HAp-free scaffold (3.5x103 kPa). The Ultimate Compression Strength 
increased by 48%, rising from 230.1 kPa of the HAp-free scaffolds to 341.2 kPa of the 
ones with HAp. The mechanical parameters here found are higher than those of the range 
reported in literature for the polymeric scaffolds (Lebourg et al., 2008; Oliveira et al., 
2006; Chung et al., 2002; Renghini et al., 2009). Hydrated gels and reswollen scaffolds 
obviously show mechanical properties about a hundredfold lower than the corresponding 
dried forms. Nevertheless, the Young’s Modulus of reswollen Alg/HAp scaffolds is about 
340% higher than that of reswollen HAp-free one (35.0 kPa vs. 8.0 kPa). 
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  E (kPa) 
σUCS 
(kPa) 
Alg/HAp 83.0 ± 9.0 - 
Gels 
Alg 20.0 ± 13.0 - 
Alg/HAp (6.3 ± 1.6)x103 341.2 ± 43.7 Dry 
Scaffolds Alg (3.5 ± 1.3)x103 230.1 ± 31.4 
Alg/HAp 35.0 ± 9.0 - Wet 
Scaffolds Alg 8.0 ± 2.3 -  
 
Figure 23: Mechanical Properties of constructs. Stress-Strain curves respectively of A): gel samples; 
B): dry scaffolds; C): wet scaffolds. For all the three graphs the red lines refers to the composite 
formulation (Alg/HAp) whereas the black one refers to the HAp-free samples (Alg). C: Summarizing 
table of mechanical properties.  
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Quantitative Three Dimension Image Analysis: Dry State 
 
One of the key requisites for bone tissue engineering scaffolds is to present a porous 
interconnected structure. The average pore size, the pore size distribution and the topology 
must be tailored to respond to specific applications requirements as they strongly influence 
cell adhesion, proliferation and matrix deposition, as well as the formation of blood vessels 
within the scaffold to help tissue ingrowth. 
While bioactive HAp reinforcements exposed on the surface of a biocomposite 
promote a stable bone-implant interface, osteoconduction and osteointegration require the 
vascularization and growth of bone into implant via an interconnected porosity, preferably 
in the 70–90% range and 200–600 µm in size (Wake et al., 1994; Wang et al., 2001; Yang 
et al., 2001).  
Micro-computed tomography is a non destructive technique that allows 
reconstruction of 3-D images of the developed scaffolds. A quantitative characterization of 
the micro-structure of the scaffold has been performed from a µ-CT reconstruction (Figure 
24).  
 
Figure 24: Three-dimensional Reconstruction of the Alg/HAp scaffold: from µ-CT segmented data of a 
freeze-casted scaffold evidencing the porosity and the interconnection of the pores. 
 
Quantification first requires a segmentation process, i.e. the separation of voxels of 
the scaffold material, hereafter conventionally named as bone, from those of background. 
This is classically done by thresholding the grey levels of the image (Otsu, 1979). Starting 
from a segmented image, a Representative Elementary Volume (REV) needs to be 
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extracted in order to have a small image (typically a regular cube) which is easy to handle 
with common computer hardware. As suggested by Bear J. (Bear, 1988), the REV size can 
be determined as the minimum value of the sub-volume size - made to progressively 
decrease - for which the calculated value of the porosity is essentially constant. The 
porosity can then be easily estimated by simply counting the number of pore (or 
background) voxels divided by the total number of REV voxels. Different methods have 
been proposed, especially within bone research, to get more refined parameters from µ-CT 
images (Accardo et al., 2005). Here, a custom implementation of the standard morphology 
parameters based on the parallel plate model (Parfitt et al., 1983) was used to achieve a 
quantification of the Trabecular Thickness (Tb.Th) and Trabecular Separation (Tb.Sp) 
(Hildebrand et al., 1999). This methodology revealed also that no isolated pores are present 
in the network. This result was achieved by means of a connected component labelling 
algorithm which counts the connected components. In this analysis the pores in contact 
with the REV margins were excluded. Numerical values of the pore size and morphology 
are comparable with those expected and present in the literature (Hildebrand et al., 1999; 
Odgaard, 1997; Rouquerol et al., 1994; Spowage et al., 2006) and considered as optimal 
for cell ingrowth and migration, diffusion of nutrients and catabolite exchange. These 
values were compared also with the features of native bone (Hildebrand et al., 1999) 
showing a good correlation of the structural parameters mainly concerning porosity, 
trabecular thickness, trabecular separation and connectivity. The structural parameters 
obtained analysing four different 400x400x400 pixels REV with 6.25 µm/voxel resolution 
are summarized in Table 4. 
 
Parameters (Hildebrand et al., 1999) Unit Present Worka 
Oliveira JM et 
al.(Oliveira et al., 
2006)  
Mathieu LM et 
al.(Mathieu et al., 
2006)  
Porosity % 80.0±2.0 59.3÷74.6 80.8÷87.8 
Tb.Th µm 37.6±6.25 − 80÷130 
Tb.Sp µm 246.8±6.25 20÷60 400÷1310 
Boneb Surface to Total Volume µm-1 9.2±0.3 E-3 − 25.2÷43.6 E-3 
Boneb Surface to Boneb Volume  µm-1 56.0±2.5 E-3 − − 
Connectivity Density µm-1 5.4±0.9 E-3 − − 
 
Table 4: Quantitative characterization of the microstructure of the Alg/HAp sample compared with 
two reported in literature for polymer composite scaffolds. 
 
a: Each value is the average of four 400x400x400 pixels REV measurements. 
b: The word “bone” conforms to literature usage: the word “solid” should actually be used instead. 
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Figure 25: 3D visualization of a 300x300x300 pixels REV with 8.33µm/voxel resolution of an Alg/HAp 
scaffold reconstructed from µ-CT data. A) In blue are reported the paths of the structure linked to the 
pore centred in the centre-bottom pore; B) paths coloured proportionally to the radius dimension of 
the maximal sphere which can be built inside of the path; C) branches of the path which are coloured 
with different colours each time that a “crossroad” is added. 
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Figure 25 reports a 3D visualization of a 300x300x300 pixels REV volume of an 
Alg/HAp scaffold reconstructed from µ-CT data. For this investigation a custom 
MATLAB code was used in order to draw all the possible paths that connect the pores of 
the structure. In Figure 25 A the paths are marked with the blue colour and highlight only 
the ones that are connected with the “starting” pore marked in bottom-centre corner. Figure 
25 B reports the paths coloured proportionally to the radius dimension of the maximal 
sphere which can be built inside of the path. Figure 25 C shows the branches of the path 
which are coloured with different colours each time that a “crossroad” is added. This 
investigation allowed to understand the interconnection of the pores and to visualize the 
possible paths that an ideal cell could follow through the structure. As it can be seen, more 
than 50 different ways (Figure 25 C) can be followed to “escape” from a single pore (the 
one marked with a crossed circle in the bottom-centre of the image). Moreover, the paths 
are characterized of pores and throats (Figure 25 B) which dimensions are variable from a 
minimum of 170µm of diameter (≅ 20voxels×8.33µm) to a maximum of 320µm (≅ 
38voxels×8.33µm). 
 
Quantitative Three Dimension Image Analysis: Wet State 
 
Architectural features of scaffolds as well as their structural properties emerged to be 
crucial factors for a correct design of constructs used in scaffold based tissue engineering 
fields. These three-dimensional matrices are required to be highly vascularized to be 
colonized by the cells of new tissue. Therefore, scaffolds have to work in a highly hydrated 
environment. Despite several authors developed various techniques in order to evaluate the 
structural features of the scaffolds in dry conditions very few can be found in literature 
concerning analyses in wet conditions. Several authors reported deep characterizations of 
the matrices and developed various techniques that can be used to evaluate the 
architectural features of the scaffolds (Hildebrand et al., 1999; Jaecques et al., 2004; Weiss 
et al., 2003; Ho and Hutmacher, 2006). All these investigations are conducted on scaffolds 
in dry state which is not the final state in which the constructs are conceived to operate. 
Scaffolds should act as cell support at the implantation site where molecular transport is 
dependent on vasculature growth and diffusion. Molecular transport would include the 
exchange of oxygen, nutrient, metabolic wastes and molecular signalling. These 
biochemical exchanges are essential for cell migration and proliferation. Therefore, it is 
fundamental to evaluate the structural features of the constructs in wet conditions in order 
                                                        Results and Discussion                                                    a 
-84- 
to guarantee a correct characterization. Here a quantification and a comparison of 
structural features of Alg-HAp based samples in both dry and wet conditions (Figure 26 A 
and B) is reported. An approach based on Micro Computed Tomography (µ-CT) analysis 
has been developed to assess the 3D morphological organization of the synthesized 
scaffolds. Recently, µ-CT revealed to be an outstanding evaluation approach which 
collimates accuracy, fastness and non-destruction of the sample while providing a 
comprehensive overview of the various morphological and architectural characteristics. 
The interconnected 3D porous structure of the scaffolds in wet conditions was 
analyzed using confocal fluorescence microscopy (CLSM) as well. Composite scaffolds 
were prepared using rhodamine 123-labelled alginate, freeze-casted, reswollen in water for 
24h and analyzed by CLSM as described in the Materials and Methods section. The laser 
visible light can penetrate into the solid material less than X-rays and therefore the 
thickness of the measurable volume of interest is limited to about 160 µm only. In spite of 
this limitation, CLSM analysis revealed that reswollen scaffolds keep the average pore size 
dimensions and interconnectivity of the dry freeze-casted ones (Figure 26 C). 
Table 5 reports the numerical values of the quantitative analysis, based on the µ-CT 
data, on both dry and reswollen Alg/HAp scaffolds. As it can be seen porosity remains 
constant despite Tb.Th increases and Tb.Sp decreases following water uptake. It has been 
calculated that the sample increases around 20% of its overall dimension. This explains 
why the porosity, which is calculated as the rate between BV and TV, remains the same in 
both dry and wet conditions. Moreover, Tb.Sp decreases its value from 246.8±6.25 µm to 
203.7±6.25 µm still remaining within the range of the correct pore size for an optimal 
vascularization process (Salgado et al., 2004; Wake et al., 1994; Wang et al., 2001; Yang 
et al., 2001). 
CLSM has been used as an alternative investigation tool to qualitatively visualize the 
3D structure of the reswollen scaffold. Thanks to its quick visualization process, compared 
to µ-CT scanning, it has been a valuable device to qualitatively check the architectural 
features of reswollen scaffolds obtained with different casting processes (data not 
reported). 
 
 
 
                                                        Results and Discussion                                                    a 
-85- 
 
 
Figure 26: Three-dimensional Reconstruction from µ-CT segmented data of an Alg/HAp freeze-casted 
scaffold in A): Dry state; B): Wet State; C): in Wet State by means of Confocal Fluorescence 
Microscopy. 
 
 
Parameters (Hildebrand et al., 1999) Unit Dry Scaffold Wet Scaffold 
Total Volume (TV) µm3 15.6±2.1 E9 18.8±1.5 E9 
Bone Volume (BV) µm3 3.2±0.7 E9 3.9±1.1 E9 
Bone Surface (BS) µm2 143.0±11.7 E6 115.0±9.1 E6 
Porosity (1-BV/TV) % 80.0±2.0 80.0±2.3 
Trabecular Thickness (Tb.Th) µm 37.6±6.25 42.7±6.25 
Trabecular Separation (Tb.Sp) µm 246.8±6.25 203.7±6.25 
Bone Surface to Total Volume (BS/TV) µm-1 9.2±1.1 E-3 6.1±1.3 E-3 
Bone Surface to Bone Volume (BS/BV) µm-1 44.7±2.5 E-3 29.5±3.1 E-3 
Connectivity Density µm-1 5.4±0.9 E-3 4.9±1.1 E-3 
 
Table 5: Quantitative characterization of the Alg/HAp scaffolds microstructure in Dry state and in 
Wet State. The terms “bone” and “trabecula” are used for the scaffold as it was real bone. 
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Reswelling Behaviour and in vitro Structural Stability 
 
Most natural polymers, including alginate, swell readily in biological fluids. It is of 
paramount importance for a scaffold intended to be used in tissue engineering protocol to 
keep its shape and mechanical stability for a time long, enough to let the cells seeded on it 
to synthesize a sufficient amount of extracellular matrix components. However, an endless 
swelling would lead to loss of mechanical integrity and production of compressive stress 
toward the surrounding tissue. A set of experiments was performed to assess the structural 
stability as well as the ability of water uptake of the synthesized 3D structures. To mimic 
the conditions of a physiological environment, these measurements were carried out also in 
simulated body fluid (SBF). The time-dependent swelling behaviours of composite 
scaffolds in water and SBF at room temperature are reported in Figure 27 A, where data 
are the average of three parallels. The reswelling of the composite Alg/HAp scaffolds did 
not significantly differ between water and SBF. As expected, in water the structure rapidly 
absorbed a high amount of solvent, reaching an equilibrium average swelling ratio of 
1400% (w/w) within 5 min; after this time, no further significant increase in sample weight 
is observed. In SBF a first rapid step of solvent uptake can be observed within 5 min (up to 
1200% of swelling ratio) followed by a very slow step of further hydration up to 1400% in 
the following 100 min. Figure 27 B reports the dissolution behaviour of the Alg/HAp 
scaffolds in water. The inset in Figure 27 B shows images of scaffolds immersed in 
deionized water respectively for 10 min (Figure 27 B, inset a) and for 4 weeks (Figure 27 
B, inset b). As it can be seen, there is a variation of around 15% of weight in dynamic 
conditions in water. This in vitro investigation was useful as a preliminary result to 
understand the dissolution behaviour of the scaffolds in reswollen conditions. Indeed, the 
effective dissolution of the construct must be tailored by means of in vivo studies in which 
the healing and regenerative processes are performed. As reported by Jones et al. (Jones et 
al., 2006) an ideal scaffold must “resorb at the same rate as the bone is repaired” therefore 
it is of paramount significance to investigate the dissolution of the construct when 
implanted in vivo. Anyway, this preliminary result allowed concluding that the construct 
has an intrinsic bias of dissolution in rehydrated conditions. Moreover, based on previous 
literature findings (Lin and Yeh, 2004; Byrne et al., 2007; Ahmed et al., 2008), it is 
reasonable to predict that the dissolution rate will reach a plateau in in vitro conditions. 
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Figure 27: Reswelling behaviour and structural stability of Alg/HAp scaffolds. A): Swelling ratio of 
scaffolds after immersion in mQ water and SBF; B): Dissolution behaviour of Alg/HAp composite 
scaffolds. Scaffolds were immersed in water for 4 weeks and loss of mass was calculated after 1, 2 3 
and 4 weeks from immersion in mQ water. Inset in B): images of scaffolds in mQ water after 10 min 
(a) and after 4 weeks (b) of immersion. 
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4.3.2. In Vitro Cell Response 
 
Cell attachment, proliferation, and differentiation are the indication of cellular 
compatibility of the material and determine its suitability for tissue engineering 
applications. The attachment and growth of osteoblast-like cell lines on Alg/HAp scaffolds 
were then assessed using MTS assay according to a protocol tailored from the one 
provided by the manufacturer. Two human osteosarcoma cell lines were used, namely 
MG63 and Saos-2. Cells were seeded on the top of the scaffolds after reswelling of the 
structures at day 0 by means of DMEM medium; the assay was performed up to days 1, 7, 
14 and 21 after initial seeding.  
 Both cell lines tested showed a good degree of proliferation after seeding onto the 
synthesized scaffolds; the main difference observed was the rate of growth displayed by 
the two cell lines.  
 
Figure 28: A): Cell proliferation of MG-63 and Saos-2 cell lines as a function of time in Alg/HAp and 
HAp-free scaffolds. MTS assay was performed at day 1, 7, 14 and 21 after initial seeding. B): ALP 
activity level of MG63 and Saos-2 cells after 1 and 21 days of culture in composite scaffolds.  
Data are expressed as mean optical density + standard error estimated (a.u. stands for arbitrary units). 
 
Figure 28 A reports the proliferation of MG63 and Saos-2 cell lines in Alg/HAp 
scaffolds in comparison with HAp-free scaffolds. This result demonstrates that HAp, 
introduced into the scaffold to foster osteointegration, does not affect the adequacy of 
alginate to sustain cell proliferation. The level of ALP activity on these composites was 
also determined after 1 and 21 days for both the cell lines with the aim to evaluate 
osteoblastic functionality and/or differentiation processes during cell growth onto the 
scaffolds. Although the ALP activity detected was slightly higher at day 21 in comparison 
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with day 1, this difference was not statistically significant (Figure 28 B). In particular, the 
expression level of ALP in MG63 cells, a partially undifferentiated cell line, remains low 
and does not show any statistically significant variation from day 1 to day 21, indicating 
that no differentiation process takes place in the scaffolds.  The cultures in Alg/HAp 
composites were analyzed for individual cell morphology after 7 and 21 days of growing 
using scanning electron microscopy (SEM).  
 
Figure 29: SEM micrographs of osteoblast-like cells seeded on Alg/HAp scaffolds: MG63 cells on 
scaffold after 1 A) and 21 B) days of culture, Saos-2 cells on scaffold after 1 C) and 21 D) days of 
culture. 
 
Figure 29 reports SEM micrographs of osteoblast like cells MG63 and Saos-2 on the 
Alg/HAp scaffolds after 7 and 21 days of culture. The majority of cells displayed a 
rounded morphology rather than a flat one and they appeared gathered together to form 
clusters, while the few others appear randomly attached on the material surface. The cells 
are well adherent to the pore walls with processes and multiple filopodia, surrounded by a 
network of fibrillar bundles of extracellular matrix particularly abundant after 21 days of 
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culture. Cells can be found both on the pores localized on the top surface of the scaffolds 
and into the inner portions of the constructs. 
 
4.3.3. In Vivo testing 
 
In order to understand the osteoinductive and osteoconductive properties of the 
Alg/HAp scaffolds in vivo tests were exploited. This investigation allowed understanding 
of the complex processes of integration and degradation of the implants in physiological 
conditions. Three different analyses were performed on ex vivo samples from femur 
dyaphises: 
- Micro Computed Tomography (µ-CT); 
- Standard Light Microscopy; 
- Confocal Laser Scanning Microscopy  
 
These analyses separately revealed the high level of osteointegration and 
osteoconduction of the scaffolds.  
 
Micro Computed Tomography Analyses 
 
µ-CT scanning allowed to observe the features of the scaffold inside the defect in the 
whole specimen. Figure 30A reports a transverse section of the specimen dissected 6 
weeks after implantation of an Alg/HAp scaffold. In this slice, three different opacities 
(grey levels) can be noticed, respectively belonging to three different components of the 
image (except for the black background). The darker grey belongs to the part of the 
scaffold which is still intact; the lighter grey represents the cortical bone, whereas the 
intermediate grey corresponds to newly formed bone. The two green boxes of Figure 30A 
highlights the front of bone growth progression, i.e. the border between the light and the 
intermediate grey. Moreover, the presence of bone callus can be detected in the upper right 
part of the image. Figure 30B and Figure 30C report respectively the sample used as 
negative control (without any implant) and the one implanted with commercial Bioactive 
Glass Scaffold taken as a positive control (Moimas et al., 2006). Both images show the 
healing defect occurred during 6 weeks after the surgery. In both cases the defect site still 
presents an unmerged area between the two cortical edges as for the defect filled with the 
Alg/HAp scaffold (Figure 30A). In Figure 31 the whole specimen is represented by means 
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of µ-CT data with the descriptive geometry procedure. In these images coloured 
segmentation of the original grey histogram was applied: pink areas correspond to the 
uncolonized scaffold whereas the yellow ones represent both the native bone and the newly 
deposited one. This images highlight the presence of new bone formation within the 
scaffold. In Figure 31 C the two white lines belong to the sectional planes of the coronal 
(Figure 31 A) and sagittal (Figure 31 B) sections. Figure 31 D displays a three dimensional 
image of the region of interest of the specimen. For this visualization, particular awareness 
in the segmentation was taken in order to highlight the presence of bone formation within 
the scaffold. In this image, indeed, the uncolonized scaffold was completely removed by 
means of digital segmentation allowing better visualization of the newly formed bone in 
the defect area. 
 
                                                        Results and Discussion                                                    a 
-92- 
 
 
 
Figure 30: µ-CT transverse sections after 6 weeks from implantation with: A) Alg/HAp scaffold 
(Magnification 3x); B) control femur: without implant (Magnification 2.5x); C) BAG scaffold used as 
commercial reference (Magnification 2.5x). 
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Figure 31: µ-CT data of a femur with Alg/HAp scaffold after 6 weeks from implantation: A) Coronal 
section; B) Sagittal section; C) Transverse section; D) Three dimensional representation. 
 
 
Light Microscopy and Histological Analyses 
 
Histological analyses are reported in the figures hereafter where the letter H is added 
to the caption (e.g. Figure H 1) for an easier consultation. Figure H 1 allows an overview 
of the sample obtained from dissection of the femur implanted with Alg/HAp scaffolds 6 
weeks after surgery. In this figure, cortical bone and bone marrow can be easily detected. 
The cone-like shape of the scaffold is still recognizable. The void in the bone marrow 
represents the part of the scaffold which has been dissolved by EDTA. At the site of the 
defect (Figure H 2) newly formed bone is visible both at level of the cortical bone edges 
and within the core of intracortically placed scaffold. On the edges of the cortical bone 
(Figure H 3 and Figure H 4), neo-deposited bone matrix can be appreciated; the green box 
in Figure H 2 highlights the front of bone growth advancing, as shown in Figure 30A 
(green boxes). Figure H 3 underlines the presence in the cortical bone of mature Haversian 
Systems intermingled with immature ones, as revealed by their larger osteonic canals 
because of uncomplete lamella centripetal apposition, consistently with normal bone 
remodelling. Moreover, in the green box of Figure H 3 lamellae of peripheral newly 
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formed bone are detectable. The same consideration can arise referring to Figure H 4, in 
which the continuity between the circumferential lamellae of native bone and those of the 
newly formed bone – parallel to the contact surface between the implant and the native 
bone – can be appreciated. Figure H 5 depicts an overview of the site of the defect, 
excluding the cortical bone, where the newly formed bone is apparent. Starting from the 
site of the defect, part of the Alg/HAp scaffold have been colonized and both osteogenesis 
and angiogenesis are present (Figure H 6). Angiogenesis is clearly detected by the presence 
of blood vessels and red blood cells in the area before occupied by the scaffold. 
Potentially, the blood vessels could provide a steady support in mesenchimal cell 
recruitment besides anabolic/catabolic functions associated with bone synthesis. 
Osteogenesis occurrence is also indicated by the presence of fibrous containing areas of 
intramembraneous ossification inside the scaffold pores (Figure H 7). Moreover, the 
presence of osteoclasts reveals the active nature of the newly deposited bone. These giant 
multinucleated cells are responsible for bone resorption and their presence ensures bone 
remodelling. Figure H 8 shows a normally structured bone marrow (with the presence of a 
lot of adipocytes, hemopoietic tissue cellularity and blood vessels), the inner aspect of 
which is lined by two superimposed osteoid-like layers; in addition, at the top of the inner 
one, considerable lamellar bone is present. In Figure H 9, the presence of osteoblasts along 
osteoid-like matrix is consistent with active bone formation. Blood vessels and osteoclast 
presence were observed in several areas of the colonized scaffold (Figure H 10) in close 
relationship with scaffold residues. In Figure H 11, a layer of mature lamellar bone lies 
between an inner layer formed by calcifying tissue, facing the void left by artifactual 
scaffold loss, and an outer layer formed by fibrous connective tissue, facing bone marrow. 
Figure H 12 shows in more detail the presence of foci of mature lamellar bone and blood 
vessels at level of the intracortical scaffold core.   
 
In vivo Fluorochrome Labelling   
 
Fluorochrome labelling reported in Figure 32 shows the kinetics of bone deposition 
during the healing period. The five different stains were able to bind the sites were the 
calcification process occurred. These stains served as markers, allowing the identification 
of the mineralized tissue at the time of dye administration. The fluorochromes were 
administrated systematically every 7 days starting at day 4 from scaffold’s implantation. 
Filters sets for confocal fluorescence microscopy were chosen either for selective 
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excitation of single fluorochrome (single images at different times), or as broad band filters 
for simultaneous visualization of all the stains (the merged lower-right image of Figure 
32). Due to their feature of chelating their active iminodiacetic groups with the apatite of 
the bone matrix, the dyes were used to labelling bone formation both in the scaffold’s 
network and at the edges of the cortical bone. The presence of fluorochromes in the images 
indicates site, time and amount of deposition and enhances the information contained in the 
bone specimen. The five different fluorochromes administrated, distinguishable by the 
pseudo-colour assigned during the scanning acquisition, are reported in the five different 
images of Figure 32. These images indicate that the bone deposition is constant during the 
healing time. Maybe, a higher amount of deposition could be assigned at week 5 but it is 
anyway comparable with the other images. The second paramount evidence is that the 
deposition started immediately after the implantation. The presence of fluorochrome, both 
at the interphase between the cortical bone and the scaffold and inside of the scaffold’s 
network, states that the Alg/HAp structure effectively support cell colonization and 
extracellular matrix deposition.  
In conclusion, each of the three methods employed separately indicated the existence 
of remarkable in vivo osteoinductive and osteoconductive capacities exhibited by the 
Alg/HAp scaffold. It has to notice that the defect was non critical, therefore a spontaneous 
healing, that should complete in a certain time – of course longer than the one that we 
handle – was expected. The aim of the in vivo investigation was, indeed, not to test the 
speed-up of the healing by means of the Alg/HAp scaffold but to test its osteoconductive 
and osteoinductive properties. This test was crucial to assess the scaffold for the following 
challenging aim which is represented by the employment of the Alg/HAp 3D structure as 
an osteoconductive coating for load bearing bone prosthesis where the circumstanced lead 
to wield with critical defects. 
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Figure H 1: Cross section of treated and unstained femur dyaphisis.  
Original magnification: 1x. 
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Figure H 2: Enlargement of Figure H 1 at level of cortical bone and outer bone marrow.  
Original magnification: 2.5x. 
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Figure H 3: Cross section at the right-side of the cortical bone in contact with the scaffold evidencing the Haversian System and the newly formed lamellar bone.  
No staining. Original magnification: 10x. 
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Figure H 4: Cross section at the left-side of the cortical bone in contact with the scaffold evidencing the native bone and the newly deposited lamellar bone.  
No staining. Original magnification: 10x. 
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Figure H 5: Alcian Blue staining shows newly formed bone at the interface between bone marrow and scaffold (removed by EDTA).  
Original magnification: 1x. 
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Figure H 6: Alcian Blue staining at the core of intracortical scaffold: taking place of both angiogenesis and osteogenesis is evident. 
Original magnification: 10x. 
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Figure H 7: Alcian Blue staining plus Hematoxylin and Eosin counterstaining evidence osteoclasts and new bone formation.  
Original magnification: 20x. 
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Figure H 8: Alcian Blue staining showing the appearance of two osteoid-like layers at the left aspect bone marrow facing the void left by EDTA-induced scaffold 
loss. Original magnification: 10x. 
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Figure H 9: Alcian Blue staining at the interface between bone marrow and scaffold.  
Original magnification 10x. 
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Figure H 10: Alcian Blue staining plus Hematoxylin and Eosin counterstaining: presence of osteoclasts and blood vessels at scaffold core.  
Original magnification 40x. 
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Figure H 11: Hematoxylin and Eosin staining at the interface between scaffold and bone marrow: presence of mature lamellar bone within the interposing 
connective tissue Original magnification: 20x. 
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Figure H 12: Hematoxylin and Eosin staining at the intracortical scaffold core. 
Original magnification: 10x. 
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Figure 32: Fluorochrome labelling of bone deposition dynamics. 
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4.4. Interlocking of the Biocomposite Scaffold with FRC 
Biomaterials for Load Bearing Applications 
 
Albeit the principal components of the prosthesis, i.e. the osteoconductive coating 
and the FRC core, have been extensively investigated here and elsewhere (Ballo et al., 
2008a; Cacciafesta et al., 2008; Tuusa et al., 2007), the adhesion between the two 
structures is still under investigation. Here, two different ways of interlocking the external 
osteoconductive coverage to the internal load bearing FRC core are presented: 
– Physical Interlocking: the outer osteoconductive coating (scaffold) is physically 
linked to the inner FRC core by interaction of the trabecular structure of the 
scaffold with the creeks produced on the FRC surface by an adequate casting. 
– Molecular Interlocking: preliminary results are reported on a hypothetical 
molecular interaction between the Alg and the calcium ions added to the surface 
of the FRC as HAp crystals. 
A novel bi-phase system of porous scaffold and FRC was here developed and the 
structural features of Scaffold-FRC system revealed a high interaction between the porous 
network (scaffold) and the FRC. This system is believed to have high potentials for bio-
medical application. The extremely high attitude (Turco et al., 2009) of hard tissue 
integration and bone ingrowth stimulation of the porous media was used here in 
combination with the ability to sustain stresses of the FRC materials (Ballo et al., 2008a; 
Ballo et al., 2008b; Cacciafesta et al., 2008; Cacciafesta et al., 2007; Le Bell-Ronnlof et al., 
2007; Garoushi et al., 2007; Tuusa et al., 2007; Tuusa et al., 2008). It allowed to consider 
this system as suitable for future applications in load bearing bone replacements. As 
reported by Vallittu et al. (Ballo et al., 2008b; Tuusa et al., 2007) FRC have a high affinity 
with the hard tissues. Moreover, the unique feature of modelling the shape of the Scaffold-
FRC system could be applied for in situ replacements and reconstructions of large critical 
hard tissue defects (i.e. cranial or jaw defects). 
 
4.4.1. Physical Interlocking 
 
Treating the FRC as reported in the Materials and Methods section it was possible to 
create a very rough surface allowing the interpenetration of the alginate gelling solution 
into the creeks of the FRC. In this way, after the gelling of Alg and treating the Alg-FRC 
system with the same thermal conditions of the scaffold, it was possible to obtain the 
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interlocking between the Alg scaffold and the FRC core. The bi-phase system of porous 
scaffold and FRC was investigated by means of µ-CT. The system revealed a high 
interconnected structure where the trabeculas of the scaffold were able to penetrate into the 
creeks of the FRC (Figure 33 and Figure 34). This feature was retained to be the 
responsible of the adhesion between the two phases. 
  
 
 
Figure 33: µ-CT of Scaffold-FRC system. 
 
 
 
Figure 34: Particular of the adhesion between the scaffold and the FRC. 
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4.4.2. Mechanical Features of Scaffold-FRC system 
 
Quantitative analyses were performed in order to understand the adhesion features 
between the two phases. So far, no literature data is presently available for the adhesion of 
biomaterial scaffolds onto solid substrates. Anyway adhesion tests were performed 
according to the standard ASTM D 2651-79 (Leung et al., 1998). 
 
4.4.3. Adhesive Test 
 
Tensile mechanical properties (ASTM D 2651-79) (Leung et al., 1998) were 
determined from stress–strain analysis of the samples (Figure 36). Adhesive failure 
between the two phases was observed for all samples as it can be seen in Figure 35 B and 
C. The data obtained for these samples revealed a Young’s Modulus of 2.1x103 ± 0.5x103 
kPa and an ultimate tensile strength of 123.0 ± 30.0kPa.  
 
 
Figure 35: Adhesion Test 1. A) Device, B) Particular of the sample connected to the device,  
C) Particular of a broken sample. 
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Figure 36: Stress-Strain analysis according to ASTM D 2651-79. 
 
4.4.4. Shear Stress Tests 
 
These tests (Figure 37) revealed cohesive failure between the two phases (Figure 37 
C). This is possibly due to the fact that the better adhesion between the two phases leads to 
an equal distribution of the shear stresses in the system. Mechanical properties were 
determined from stress–strain analysis of the samples (Figure 38): a maximum shear stress 
(τMAX) of 230.0 ± 30.0 kPa was achieved. 
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Figure 37: Shear Stress Test. A) Device, B) Particular of the sample connected to the device,  
C) Particular of a broken sample. 
 
 
 
Figure 38: Stress-Strain analysis based on Shear-Stress Tests. 
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These mechanical tests were of paramount relevance to understand the behaviour of 
the system under loading conditions. Albeit the ultimate stresses are still in the kPa 
domain, the adhesion between the two phases – scaffold and FRC – is believed to be 
adequate for the stresses that the final prosthesis will bear. Indeed, the stresses that the 
scaffold-FRC bi-phase system will undergo correspond to the ones involved during the 
implant surgery and to the first stages of healing when the site of the defect is exposed only 
to physiological mechanical stimuli and must not bear loads. After the healing period, the 
temporary phase of the prosthesis, i.e. the scaffold, should be remodelled and replaced by a 
novel bone which encompass the FRC core regaining the native mechanical properties to 
the bone. 
 
4.4.5. Molecular Interlocking 
 
As previously reported, this is a preliminary investigation on the possible interaction 
between the Alg solution and the calcium ions of HAp present on the surface of the FRC. 
HAp crystals have been included into the outer surface of the FRC as reported in the 
Materials and Methods section. With this procedure we obtained a construct which was 
named: Calcium Enwrapped Resins (CER). A source of calcium ions was therefore 
available for the gelification of the Alg solution directly from the FRC allowing a 
molecular interaction between the two phases. Two different formulations of resin for the 
FRC system have been investigated. The first formulation, namely F1, (see Materials and 
Methods for details) is a light-curable resin which is commonly used in dental and medical 
application to replace metal and polymer materials. Despite its wide usage, this resin seems 
to release a low amount of residual monomers into water or physiological environments 
due to an incomplete double bond conversion after polymerization (Floyd and Dickens, 
2006; Väkiparta et al., 2006; Cerveira et al., 2010).  
In vitro tests on extracts from CER constructs with F1 resin in both DMEM and 
McCoy's culture mediums revealed that the amount of residual monomers released in the 
mediums was toxic for both the cell lines, respectively MG-63 and Saos-2 osteosarcoma, 
leading to a complete death in one single day of the 20×103 cells seeded for the adhesion 
tests. We believe that the outer layer of HAp crystals could act as a shield for the UV light 
necessary for the total polymerization of the resin. Moreover, the site of the CER construct 
which presents the higher amount of monomers unreacted is exactly the one more reach in 
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HAp which is also the site supposed to interact with the Alg solution and therefore with the 
cells of the boundary tissues. 
These results pointed the way of changing the resin composition maintaining the 
construct casting procedure. The second composition investigated (F3) was Bis-
GMA/TEGDMA resin where the polymerization was initiated by heating with benzoyl 
peroxide (BPO) as initiator (Kalachandra and Turner, 1987; Sideridou et al., 2006). This 
procedure allowed to overcome the flaws of the F1 resin and to produce a CER construct 
which was not only un-toxic but also stimulated the proliferation of the in vitro tested cells. 
Moreover, as reported in Figure 39 the proliferation rate of the cells seeded on the CER 
samples was higher than the one observed for the same cells seeded on the bare F3 resin. 
This result allowed to conclude that the CER construct developed with the F3 resin was a 
potential candidate for the anchoring substrate of the Alg scaffold. 
 
Figure 39: MG-63 osteosarcoma cell-line proliferation on CER  
 
Future work will include proliferation test for the Scaffold-FRC bi-phase system and 
set up of a casting workflow for the CER-F3 able to link the resin substrate with the Alg 
scaffold. Moreover, particular attention will be assessed on the mechanical properties of 
this final construct.  
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5. CONCLUSIONS 
 
In this work osteoconductive coatings for bone prosthesis based on fibre-reinforced 
polymethacrylate resins were developed. The goal of casting of reproducible 3D structures 
which could mimic the architectural and biological features of the native trabecular bone 
was achieved. 
 
The first part of the work dealt with the development and characterization of 
composite scaffolds based on Alg and HAp. The casting strategy exploited a novel method 
based on the sequential (i) formation of a homogeneous gel stabilized by calcium ions 
uniformly released from a HAp reservoir; (ii) freeze-casting of the gel, which allowed to 
obtain macroporous interconnected scaffolds. The characterization of the single 
components of the structure, Alg and HAp, allowed retaining these two constituents as 
suitable for the aim settled. A detailed morphological analysis of the final 3D structure 
revealed an interconnected and isotropic pore network with a range of pore size considered 
optimal to obtain good osteointegration and osteoconduction. Compressive tests indicated 
that addition of HAp induces a remarkable increase of mechanical features of composites 
when compared to those of pure alginate scaffolds. The composite scaffolds display a high 
structural wettability and stability both in water and in physiological solutions. 
 
Preliminary biological tests allowed to evaluate cells attachment and penetration 
leading to conclude that the scaffold sustain efficiently osteoblast proliferation in vitro. 
Cell morphology, viability and proliferation were examined. In vivo bone ingrowth was 
assessed on the Alg/HAp structures after 6 weeks from the surgery. Newly formed bone 
was observed at the bone-implant junctions. 
 
Finally, the interlocking of the porous structure to the load-bearing core was 
investigated. For this aim two strategies were followed: physical and molecular 
interlocking. Albeit the former process was more exhaustively described, both the 
approaches appear as promising to obtain a final construct able to biologically interact with 
the surrounding native bone tissue and to sustain the loads of an orthopaedic prosthesis. 
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The findings of the present study revealed that the structures here developed could 
serve as a promising alternative to metallic prostheses in the orthopaedic framework. 
However, more studies concerning mechanical characterization, optimization of the 
fabrication techniques and higher statistically valuable biological investigations are 
needed.  
Work is in progress to further tune the biological performance of Alg/HAp scaffolds 
by insertion of suitable bioactive compounds. One important aspect to be investigated 
deals with the optimization of the sterilization process for this new type of scaffold, not to 
harm such delicate molecules. 
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